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Abstract 
 
The antimicrobial activity of essential oils is discussed in this review taking in 
account studies which were published in the period of time from 2008 until 
September 2010. Furthermore, the most important methods to examine the 
antimicrobial efficiency of essential oils are presented. The studies are divided into 
the following three groups depending on the activity of the applied essential oil 
against the test microorganisms: antimicrobial, antifungal active agents and 
substances which inhibit the growth of yeasts. Various interesting possible 
applications are revealed such as the use of essential oils instead of synthetic drugs to 
circumvent the increasing resistance of some pathogens. Moreover, they could not 
only be used for the therapy of infectious illnesses, but also as preservatives in the 
food industry. A further possibility is among others the application of essential oils in 
skin products in order to treat or avoid dermal infections. Additionally, the prevalent 
constituents of the individual antimicrobial active essential oils are elaborated. 
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Zusammenfassung 
 
Die antimikrobielle Wirkung von ätherischen Ölen wird in diesem Review unter 
Berücksichtigung von Studien, die in der Zeitspanne von 2008 bis September 2010 
veröffentlicht wurden, diskutiert. Außerdem werden die wichtigsten Methoden zur 
Bestimmung der antimikrobiellen Wirksamkeit von ätherischen Ölen präsentiert. Die 
Studien werden in die folgenden drei Gruppen unterteilt, abhängig von der Aktivität 
des verwendeten ätherischen Öls gegen die Testkeime: antimikrobielle, antifungale 
Wirkstoffe und Substanzen, die das Wachstum von Hefen hemmen. Verschiedene 
interessante Anwendungsmöglichkeiten werden aufgezeigt, wie zum Beispiel die 
Anwendung von ätherischen Ölen an Stelle von synthetischen Wirkstoffen, um die 
ansteigende Resistenz von einigen Pathogenen zu umgehen. Außerdem können sie 
nicht nur zur Therapie von infektiösen Erkrankungen eingesetzt werden, sondern 
auch als Konservierungsmittel in der Lebensmittelindustrie. Eine weitere 
Möglichkeit ist unter anderem die Anwendung von ätherischen Ölen in 
Hautprodukten, um dermale Infektionen zu behandeln oder zu vermeiden. Des 
Weiteren sind die vorherrschenden Bestandteile der einzelnen antimikrobiell 
wirksamen ätherischen Öle ausgearbeitet. 
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INTRODUCTION 
 
Essential oils (EOs) possess a wide spectrum of different impressive qualities 
including antiphlogistic, spasmolythic, antinociceptive and antioxidant activity. 
Moreover they exert immunomodulant, psychotrope, acaricide and expectorant 
effects.
[1]
Due to their multifunctionality, EOs find a huge application area in 
medicine and aromatherapy. 
 
Also antiviral, antidiabetic and cancer suppressive activities are observed. In addition 
to further other effects, EOs show significant antimicrobial properties against a wide 
range of Gram-positive and Gram-negative bacteria. That is why they were already 
used for embalming in Ancient Egypt.
[2]
 
In the course of history EOs were always applied for their antimicrobial effects in 
traditional medicine. Therefore, plants were used for the treatment of infectious 
illnesses since ancient times even though no knowledge about microorganisms 
existed by then.
[3]
 
 
Medicinal plants are of course still in use nowadays, but now the investigation of the 
active agents is possible by modern means. The isolation of EOs and their 
characterization by using gas chromatography (GC) and mass spectrometry (MS) 
systems are common practice. Moreover their antimicrobial activity can be verified 
by in-vitro tests. EOs get even more popular regarding the fact that many synthetic 
drugs are connected with unpleasant side-effects. Volatile oils also represent an 
interesting alternative due to emerging resistance of microorganisms against 
synthetic agents. 
 
EOs cannot only exert bacteriostatic and bactericidal effects, but also demonstrate 
activity against fungi and yeasts. 
This paper focuses on the antimicrobial and antifungal activity of EOs concentrating 
on studies that have been published since 2008 until September 2010. 
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IN VITRO TESTS TO ASSESS ANTIMICROBIAL ACTIVITY  
 
Several methods are used to investigate the antimicrobial activity of EOs. The three 
most important ones are: The agar diffusion test, the agar or broth dilution test and 
the vapour phase test.
[4]
 
 
Agar Diffusion Test: 
A petri dish filled with microorganisms containing agar is needed to perform this 
method. The EO is either directly applied to the surface – in this case small holes are 
punched into the agar surface - or put on a small paper disk which is afterwards 
placed onto the agar. The antimicrobial activity can be estimated from the size of the 
originating inhibition zone. Nevertheless it is important to point out that this test 
method is not completely free of any problems. This conclusion can be drawn from 
the fact that in some cases the results of the agar diffusion test showed small 
antimicrobial activity, but the same EO proved high activity in dilution tests. 
Especially components with low water solubility showed misleadingly low 
antimicrobial activity. Moreover the different volatility of single constituents, then 
often unknown diffusion coefficients and other side effects have to be considered.
[4]
 
 
Dilution Test: 
In the broth dilution test concentration series of the antimicrobial substance are 
established using a broth medium which is seeded with microorganisms. The 
minimal inhibitory concentration (MIC) is evaluated in order to determine the 
antimicrobial potency of the tested substance. 
In the agar dilution test a concentration gradient of the tested substance is placed 
onto an agar plate. By evaluating the microbial growth the MIC can be stated 
likewise. This method is declared to be the gold standard but it is not that often used 
since it is connected to higher costs and laborious handling.
[5]
 
When performing the dilution test method with EOs it is adjuvant to create a 
saturated moistened atmosphere to adjust volatility.
[4]
 
 
Vapour Phase Test: 
Up to now, there is no standardized method available for the vapour phase test. In 
general, a seeded agar plate is placed upside-down onto a reservoir which comprises 
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a certain amount of volatile oil. In this case the generated inhibition zone is 
considered as criterion for the antimicrobial activity.
[4]
 
 
Aromatogram: 
The procedure of developing an aromatogram resembles the agar diffusion test. That 
is why the test microorganisms which are cultivated on an agar plate are exposed to 
certain amounts of EOs which are spread on paper disks. The antimicrobial efficacy 
of the EO is likewise determined by inhibition zones.
[6]
  
The crucial difference between these two techniques is not the course of action itself, 
but the substances which are investigated for their potentially antimicrobial activity. 
Therefore, aromatograms always indicate the use of exclusively EOs whereas 
antibiograms include also other active substances such as synthetic drugs.
[7]
 
 
Air washer coupled with Air Sampler: 
This test method allows the determination of the antimicrobial activity of EOs 
against air-borne microbes. A special machine called air washer is filled with diluted 
EO which is vaporized into the room. By the air sampler air-borne microorganisms 
are fixed on agar strips. After incubating these strips the number of microbes in the 
air can be counted. As a result, the comparison between the amount of bacteria 
before and after the application of EO vapours is facilitated.
[8]
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ANTIMICROBIALS 
 
Antimicrobial agents inhibit the growth of microorganisms or lead to their death. In 
the following chapter studies are presented that deal with the effect of EOs on 
bacteria and yeasts. 
 
Former studies indicate a higher antibacterial effect of EOs against Gram-positive 
than against Gram-negative bacteria. The outer cell membrane of Gram-negative 
bacteria obtains hydrophilic qualities that impede the contact of the hydrophobic 
constituents of the EO with the bacterial cell.
[9]
 
Contrary to this, EOs can directly impair the cell membrane of Gram-positive 
bacteria leading to cell membrane rupture, blocking of enzyme systems and 
progressivity of ion permeability.
[10]
 
 
 
EOs against drug-resistant bacteria strains 
 
The increasing tolerance of several microorganisms against commonly used 
antibiotic drugs represents a challenge for scientists to find alternative ways for the 
treatment of such infections. One of the main causes that provokes the higher 
resistance of microorganisms is the loose application of drugs.
[11]
 This includes that 
they are applied in too low concentrations, not specific enough or without serious 
indication. Especially methicillin-resistant Staphylococcus aureus (MRSA) strains are 
popular test microorganisms.  
 
S. aureus – a Gram-positive bacterium which is common part of the human microbial 
skin flora - can cause minor infections, but nevertheless also severe diseases such as 
pneumonia, sepsis, endocarditis or meningitis particularly in hospitalized patients. 
The increasing resistance of these pathogens against current drugs tremendously 
complicates the therapy of these infections.
[12]
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effective 
against 
EO main constituents test method Ref. 
MRSA, 
vancomycin-
resistant 
Enterococcus 
faecium 
(VRE), 
multidrug-
resistant 
strains of 
Klebsiella 
pneumoniae 
and 
Pseudomonas 
aeruginosa  
Cleistocalyx 
operculatus 
(Roxb.) Merr and 
Perry (Myrtaceae) 
γ-terpinene 
(5.8%) globulol 
(5.6%)  
cis-linalool oxide 
(5.2%) 
MIC = 5 - 20 
l/ml 
[13]
 
MRSA Eucalyptus 
globulus Labill. 
(Myrtaceae) 
1,8-cineole 
(47.2%) 
MIC = 85.6 
g/ml 
[14]
 
 
 
MRSA, VRE Kadsura 
longipedunculata 
Finet & 
Gagnepain 
(Schisandraceae) 
-cadinene 
(21.8%) 
diffusion test, 
dilution test 
[15]
 
MRSA Lavandula 
angustifolia Mill. 
(Lamiaceae) 
linalyl acetate 
(37.0%), linalool 
(29.5%) 
disk diffusion 
[16]
 
MRSA Lavandula 
latifolia Medik 
(Lamiaceae) 
linalool (38.8%), 
1,8-cineole 
(28.5%) 
disk diffusion 
[16]
 
MRSA Lavandula 
luisieri Rozeira 
Riv.-Mart. 
(Lamiaceae) 
-necrodyl 
acetate (34.5%), 
 1,8-cineole 
(17.6%) 
disk diffusion 
[16]
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MRSA Lavandula 
stoechas L. ssp. 
stoechas 
(Lamiaceae) 
-fenchone (39.2%), 
myrtenyl acetate 
(9.5%), 
 -pinene (6.1%), 
camphor (5.9%) 
MIC = 31.2 
g/ml 
[17]
 
MRSA Salvia rosifolia 
Sm. 
(Lamiaceae) 
-pinene, 
1,8-cineole 
MIC = 125 
g/ml 
[18]
 
MRSA Tanacetum 
parthenium (L.) 
Schultz Bip. 
(Asteraceae) 
camphor (49.0-60.8%) MIC = 125 
g/ml 
[19]
 
MRSA Thymus 
vulgaris L. 
(Lamiaceae) 
thymol (48.1%) MIC = 18.5 
g/ml 
[14]
 
MRSA Zataria 
multiflora 
Boiss. 
(Lamiaceae) 
thymol (38.7%), 
carvacrol (15.3%), rho-
cymene (10.2%) 
MIC = 0.25-
1.0 l/ml 
MBC = 0.5-
2.0 l/ml 
[20]
 
MRSA Zanthoxylum 
tingoassuiba 
St.-Hil. 
(Rutaceae) 
-bisabolol, methyl-N-
methylanthranilate 
disk 
diffusion 
[21]
 
 
Table 1: EOs and MRSA 
 
Helichrysum italicum (Roth) G.Don fil. (Asteraceae) EO which contained among 
other constituents geraniol showed an inhibitory activity against multidrug resistant 
strains of the Gram-negative bacteria Acinetobacter baumannii, Enterobacter 
aerogenes, Escherichia coli and P. aeruginosa. The susceptibility of these pathogens 
was considerably enhanced by combining commonly used drugs such as -lactams, 
chloramphenicol and quinolones with geraniol. H. italicum EO was presumed to 
obtain substances which act as efflux pump inhibitors since the EO revealed to be 
 12 
especially active against bacteria which over-expressed efflux pumps and therefore 
developed tolerance towards drugs.
[22]
 
 
The volatile oil of Melaleuca alternifolia Cheel. (Myrtaceae) comprises among other 
constituents the antimicrobial active agent terpinen-4-ol. In in-vitro tests the 
bacteriostatic and bactericidal activity of both M. alternifolia EO and its isolated 
component terpinen-4-ol was ascertained against coagulase-negative staphylococci 
and MRSA showing much stronger activity when using terpinen-4-ol on its own. As a 
consequence terpinen-4-ol could constitute an interesting alternative in the therapy of 
MRSA infections of the skin.
[23]
 MRSA and MSSA strains got adjusted to M. 
alternifolia EO when it was applied at sub-lethal concentrations. These strains 
developed higher resistance to the EO but also to antibiotics. After the same 
treatment coagulase-negative Staphylococci showed likewise lower vulnerability to 
antibiotics, but the effect of M. alternifolia EO was not decreased. Therefore, it is 
important to use EOs in high enough concentrations to avoid this adaptation.
[24]
 
 
The above mentioned results support the idea of using EOs as an alternative to well-
established drugs since they show high efficacy in inhibiting drug-resistant bacteria 
strains. The EOs could be used on their own, but also in combination with other EOs 
or synthetic active agents since synergy was observed by combining these substances. 
Therefore, synergistic effects were noticed regarding Z. multiflora EO in 
combination with the synthetic active agent vancomycin
[20]
, but also when combining 
different EOs such as L. luisieri EO with L. angustifolia or L. stoechas EO.
[16]
 
 
 
EOs against Propionibacterium acnes and Staphylococcus epidermidis 
 
The following studies show that EOs are capable of inhibiting the growth of bacteria 
which are linked to the occurrence of skin infections, such as P. acnes, 
Propionibacterium granulosum
[25]
 or S. epidermidis. Interestingly, no differences 
were noticed between the activity against drug-sensitive and drug-resistant bacteria 
strains.
[26]
 Due to that, EOs could be used in acne therapy or in cosmetic products for 
the prevention and treatment of skin infections.
[27]
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effective against EO main constituents test method Ref. 
P. acnes, 
S. epidermidis  
Abies koreana 
E.H.Wilson 
(Pinaceae) 
bornyl acetate 
(30.4%), 
limonene (19.0%) 
 
[28]
 
S. epidermidis Acronychia 
pedunculata (L.) 
Miq. (Rutaceae) 
-pinene 
(57.4%), (E)--
caryophyllene 
(13.6%) 
 
[29]
 
P. acnes, 
S. epidermidis 
Citrus natsudaidai 
Hayata (Rutaceae) 
limonene (81.6%) MIC = 0.31 
l/ml 
MIC = 10.0 
l/ml 
[27]
 
P. acnes, 
S. epidermidis 
Citrus obovoidea 
Hort. ex Takahash 
(Rutaceae) 
limonene (83.4%) MIC = 0.31 
l/ml 
MIC = 2.5 
l/ml 
[27]
 
P. acnes,  
S. epidermidis 
Citrus sunki Hort. 
ex. Tan. (Rutaceae) 
dl-limonene 
(68.2%) 
 
[30]
 
P. acnes several Citrus 
species (Rutaceae) 
limonene (67.7 to 
91.7%), myrcene 
(2.6 to 25.3%) 
MIC = 1.25 to 
20 l/ml 
[31]
 
 
 
P. acnes, 
S. epidermidis  
Cryptomeria 
japonica (Thunb. 
ex L. f.) D.Don 
(Cupressaceae) 
kaurene (17.2%), 
elemol (10.9%), 
-eudesmol 
(9.4%), sabinene 
(8.9%) 
MIC = 0.156 
to 10.00 l/ml 
[26]
 
P. acnes,  
S. epidermidis 
Fortunella japonica 
(Thunb.) Swingle 
var. margarita 
(Swingle) Makino 
(Rutaceae) 
dl-limonene 
(61.6%) 
 
[30]
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S. epidermidis Helichrysum 
pallasii (Spreng.) 
Ledeb.  
(Asteraceae) 
hexadecanoic 
acid (14.7%), 
(Z,Z)-9,12-
octadecadienoic 
acid (14.2%)  
MIC = 100 
g/ml 
[32]
 
P. acnes Syzygium 
aromaticum (L.) 
Merr. Et Perry 
(Myrtaceae) S. 
aromaticum 
 agar diffusion 
tests, MIC = 
0.31 mg/ml 
[33]
 
P. 
granulosum, 
P. acnes 
Thymus 
quinquecostatus 
Celak. (Lamiaceae) 
p-cymen-3-ol 
(50.4%), p-
cymen-2-ol 
(24.1%), cymene 
(19.0%) 
disk diffusion 
method, 
MIC = 0.5 
mg/ml 
[25]
 
 
Table 2: EOs against skin infections 
 
Also linalool and -terpineol revealed high efficiency against P. acnes and S. 
epidermidis with MICs ranging from 0.625 to 1.25 l/ml.[27] 
 
By regarding the chemical composition of the individual EOs which exert 
antibacterial activity against P. acnes and S. epidermidis the presence of limonene in 
most of these EOs stands out. In general, the EOs are predominated by non-phenolic 
monoterpenes.  
 
 
EOs against Helicobacter pylori 
 
H. pylori is a Gram-negative bacterium which colonizes the stomach of many people. 
On the one hand these infections can proceed without any symptoms, but on the 
other hand ulcers and gastritis can occur. These complications are treated with 
proton-pump-inhibitors in combination with antibiotics.
[34]
 Also EOs possess 
antibacterial activity against H. pylori. 
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effective against EO main constituents test method Ref. 
H.  pylori Apium nodiflorum 
(L.) Lag. 
(Apiaceae) 
limonene (27.7%), 
p-cymene (23.1%), 
myristicine (18.5%) 
MIC = 12.5 
g/ml 
[35]
 
H. pylori Plinia 
cerrocampanensis 
Barrie 
(Myrtaceae) 
-bisabolol 
(42.8%) 
MIC = 62.5 
g/ml 
[36]
 
H. pylori Thymus 
caramanicus 
Jalas (Lamiaceae) 
carvacrol (68.9%) Disk 
diffusion 
test,  
 MIC = 14.5 
to 58.0 
g/ml 
[37]
 
 
Table 3: EOs against Helicobacter pylori 
 
The EO of Dittrichia viscosa subsp. revoluta (Hoffmanns. & Link) P.Silva & Tutin 
(Asteraceae) comprised 3-methoxy cuminyl isobutyrate (12%), α-cadinol (6.3%) and 
eudesm-6-en-4α-ol (4.8%). The number of H. pylori bacteria significantly decreased 
using a concentration of 0.33 l/ml. Especially oxygenated compounds contributed 
to the antibacterial effect.
[38]
 
 
 
EOs as food-preservatives/ EOs against food-related bacteria 
 
The use of EOs as biopreservatives is a matter of great interest for the food industry 
since the consumers prefer natural additives instead of synthetic ones. That is why lot 
of studies were performed on this subject in the last years.
[39]
  
 
effective against EO main constituents test method Ref. 
Bacillus cereus, 
Listeria 
monocytogenes 
Artemisia 
echegarayi 
Hieron. 
camphor, thujone disk diffusion 
test, dilution 
test 
[40]
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(Asteraceae) 
L. 
monocytogenes, 
S. aureus; B. 
cereus,  
Enterobacter 
cloacea 
Artemisia incana 
(L.) Druce 
(Asteraceae) 
camphor (19.0%), 
borneol (18.9%), 
1,8-cineole 
(14.5%) 
MIC = 31.3 
g/ml; 
MIC = 125 
g/ml 
[41]
 
Salmonella 
typhi, E. coli 
Chaerophyllum 
macropodum 
Boiss. (Apiaceae) 
trans--ocimene, 
myristicin 
microdilution 
broth test 
[42]
 
S. typhi, E. coli Chrysanthemum 
parthenium (L.) 
Bernh. 
(Asteraceae) 
-pinene, 
camphor 
microdilution 
broth test 
[43]
 
E. aerogenes, E. 
coli, L. 
monocytogenes, 
S. aureus, 
Salmonella 
enteritidis, 
Salmonella 
typhimurium  
C. operculatus  γ-terpinene 
(5.8%), globulol 
(5.6%), cis-
linalool oxide 
(5.2%) 
disk diffusion 
test, 
MIC = 1 to 4 
l/ml 
[13]
 
Salmonella 
species 
Citrus species (+)-limonene, 
terpenes 
MIC = 1% 
[44]
 
E. coli Jasminum 
sambac (L.) 
Aiton (Oleaceae) 
methyl salicylate, 
benzyl acetate, 
methyl 
anthranilate 
MIC = 31.25 
μl/ml 
[45]
 
Enterococcus 
faecalis, L. 
monocytogenes, 
S. aureus; 
B. cereus; 
Yersinia 
Laurus nobilis L. 
(Lauraceae) 
1,8-cineole (60%) MIC = 0.02% 
(v/v); 
 
MIC = 0.2%; 
 
MIC = 1.0% 
[46]
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enterocolitica 
S. aureus, 
Vibrio 
cholerae; 
B. cereus, E. 
coli, L. 
monocytogenes, 
S. typhimurium 
Mentha pulegium 
L. (Lamiacae) 
piperitone 
(38.0%), 
piperitenone 
(33.0%) 
MIC = 0.5 
l/ml 
 
 
MIC = 1.0 to 
4.0 l/ml 
[47]
 
S. typhi, 
Bacillus subtilis 
Minthostachys 
mollis (Kunth) 
Griseb Vaught 
var. mollis 
(Lamiaceae) 
pulegone 
(55.2%), trans-
menthone 
(31.5%) 
MIC = 4 g/ml 
[48]
 
S. aureus; 
B. subtilis, P. 
aeruginosa, L. 
monocytogenes; 
S. typhimurium 
Nandina 
domestica Thunb. 
(Berberidaceae) 
1-indolizino-
carbazole 
(19.7%),  
2-pentanone 
(16.4%) 
agar diffusion 
assays, MIC = 
62.5 µg/ml; 
MIC =125 
µg/ml; 
MIC= 500  
µg/ml 
[49]
 
S. enteritidis Ocimum 
basilicum L. 
(Lamiaceae) 
linalool (64.4%), 
1,8-cineole 
(12.3%) 
MIC = 20.0 to 
80.0 g/ml 
[50]
 
E. coli, 
Salmonella 
enterica 
enterica 
Phoebe 
lanceolata (Nees) 
Nees (Lauraceae) 
β-caryophyllene 
(27.4%), 1,8-
cineole (18.2%) 
disk diffusion 
test, dilution 
test 
[51]
 
E. faecalis Retama raetam 
(Forssk.) Webb 
(Fabaceae) 
nonanal (35.8%), 
-humulene 
(29.3%) 
MIC = 0.625 
mg/ml 
[52]
 
E. coli; 
P. aeruginosa, 
E. faecalis 
Salvia officinalis 
L. (Lamiaceae) 
1,8-cineole 
(33.3%), -
thujone (18.4%) 
MIC = 4.5 
mg/ml; 
 MICs = 9 
mg/ml 
[53]
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E. coli, E. 
faecalis 
Schinus molle L. 
(Anacardiaceae) 
-phellandrene 
(35.9%), -
phellandrene 
(29.3%) 
MICs = 9 
mg/ml 
[53]
 
B. cereus Tanacetum 
argenteum (Lam.) 
Willd. ssp. 
argenteum 
(Asteraceae) 
-pinene 
(36.7%), -pinene 
(27.5%) 
MIC = 125 
g/ml 
 
[54]
 
B. cereus Tanacetum 
argyrophyllum 
(C. Koch) Tvzel 
var. 
argyrophyllum 
(Asteraceae) 
camphor, borneol 
and 1,8-cineole 
MIC = 125 
g/ml 
[55]
 
L. 
monocytogenes 
Zizyphus jujuba 
Mill. 
(Rhamnaceae) 
eugenol (48.3%), 
isoeugenol 
(11.8%) 
agar disk 
diffusion test, 
dilution test 
[56]
 
B. cereus, E. 
coli, L. 
monocytogenes, 
S. enteritidis, 
Proteus 
mirabilis 
T. vulgaris,  
Origanum 
vulgare L. 
(Lamiaceae),  
S. aromaticum, 
Citrus sinensis 
(L.) Osbeck 
(Rutaceae) 
 disk diffusion 
test 
[57]
 
 
Table 4: EOs as biopreservatives 
 
Not only classic in-vitro tests were conducted to investigate the antimicrobial activity. 
Therefore, the EOs were also applied on different media (e.g. meat). Subsequently, 
the effect on the microbial growth was observed over a period of time. Such studies 
are mentioned here: 
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Govaris et al. investigated the usage of Origanum vulgare subsp. hirtum Link. 
(Lamiaceae) EO as food preservative. Therefore it was either applied alone at a 
percentage of 0.6 or 0.9% or in combination with nisin in minced sheep meat. When 
the EO which primarily consisted of carvacrol (80.2%) was used singularly at a 
percentage of 0.9%, it exerted quite high activity against S. enteritis, whereas the use 
of nisin alone did not harm these pathogens. Even bactericidal activity was observed 
when the EO was combined with nisin.
[58]
 Another study about O. vulgare EO 
verifies the antimicrobial effect against S. aureus. The germ’s growth and its 
enterotoxin synthesis were inhibited by the volatile oil. Since this EO is especially 
powerful against foodborne bacteria, it might be used as biopreservative in food-
industry.
[59]
 
 
A research was performed in which edible tomato puree films were produced which 
were containing allspice, oregano and garlic EO in order to impair microbial growth. 
This method might be used in food industry for the extension of shelf life. The 
antibacterial effect against E. coli, L. monocytogenes and S. enterica was evaluated 
by vapor phase and overlay diffusion tests. Oregano EO – rich in carvacrol (63.4%) - 
obtained the strongest antibacterial effect, but also allspice EO which contained 
68.6% eugenol and garlic EO (dominated by diallyl disulfide) showed antibacterial 
effects. L. monocytogenes revealed to be the most vulnerable pathogen. All three 
bacteria were inhibited by direct contact as well as by the vapors.
[60]
 
 
Aim of a further study was to investigate the consequence of adding Origanum onites 
L. (Lamiaceae) EO containing pads to wrapped chicken drumsticks concerning the 
food’s shelf-life. The storability was prolonged from three to five days using 5 ml of 
the diluted EO (1.5%) due to the fact that the number of enterobacteriaceae, lactic 
acid bacteria, pseudomonads, psychrotrophs and yeasts was kept down. 
Unfortunately, the chemical composition of this EO was not investigated in this 
research.
[61]
 
 
T. vulgaris EO was incorporated at a concentration of 0.6% in minced beef meat. 
Higher concentrations could not be applied since they proved disadvantageous for 
the food flavor. The growth of L. monocytogenes bacteria was effectively inhibited 
especially at storage at 10 degrees. Moreover synergy was observed in combination 
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with nisin. Therefore the number of these pathogens revealed to be lower than the 
official boundary value determined by the EU when nisin (1000 IU/g) and T. 
vulgaris EO (0.6%) were applied and when the meat was subsequently refrigerated at 
4 degrees.
[62]
 
 
Cinnamaldehyde was capable of inhibiting the growth of B. cereus in nutrient and 
carrot broth at a concentration of 2l/100ml stored at a temperature of 12 degrees, 
whereas the application of eugenol and carvacrol was ineffective. That is why 
cinnamaldehyde could be used for the preservation of food based on carrots.
[63]
 
The inhibitory potency of carvacrol and cinnamaldehyde was also evaluated against 
the food-poisoning causing pathogen Campylobacter jejuni. Both EO components 
were effective at concentrations from 0.1% upwards independent on the potential 
resistance of the individual strains against drugs. Cinnamaldehyde was noticed to 
exert even stronger antibacterial agency in comparison to carvacrol.
[64]
 
 
Various EO compounds were tested for their antibacterial activity against 
Clostridium perfringens. Trans-cinnamaldehyde, 2-tert-butyl-6-methylphenol, 
carvacrol and geraniol showed the strongest activity with MICs of 167 μg/ml, 175 
μg/ml, 300 μg/ml and 450 μg/ml, respectively. Contrary to this, Lactobacillus strains 
which are part of the natural intestinal flora were not harmed.
[65]
 
 
The following study shows that there exists a certain framework of the concentration 
in which the tested EO is efficient against pathogenic bacteria, but does not yet exert 
any influence on the salutary bacteria of the gastrointestinal tract: The EO of 
Foeniculum vulgare var. azoricum (Mill.) Thell. (Apiaceae) appeared to be rich in 
the antimicrobial active agent (E)-anethole (59.3-71.7%). The EO exhibited 
antimicrobial effect against a large number of foodborne pathogenic bacteria, but 
also against probiotic bacteria such as Lactobacillus strains and Streptococcus 
thermophilus. The lowest MIC value of 15.62 g/ml was measured against 
Acinetobacter lwoffi, followed by a MIC of 31.25 g/ml against S. aureus and P. 
aeruginosa. The inhibiting effect on probiotic bacteria was reported at MIC values 
superior than 250 g/ml. Due to its antimicrobial effect against food related 
pathogens the EO could be used as food preservative, but one has to keep in mind 
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that the exaggerated ingestion of fennel products could influence the bacterial flora 
in the gastrointestinal tract by inhibiting the growth of probiotic bacteria.
[66]
  
 
A study was conducted about the usage of specific EOs for the therapy of 
gastrointestinal dysbiosis, an imbalance of the intestinal microflora. Therefore, the 
effect of eight EOs which are traditionally used for the treatment of gastrointestinal 
ailments and diseases was examined by MIC evaluation against Bacteroides fragilis, 
Clostridium difficile, C. perfringens, E. faecalis, E. coli, Eubacterium limosum, 
Bifidobacterium bifidu, Bifidobacterium longum, Lactobacillus acidophilus, 
Lactobacillus plantarum, Peptostreptococcus anaerobius and Candida albicans. The 
volatile oil of Trachyspermum copticum (L.) Link (Apiaceae) exhibited the strongest 
antibacterial effect since it stopped bacterial growth of all tested germs at 
concentrations lower than 2.2%. Moreover, it revealed high selectivity against 
pathogenic bacteria. The same is true for Carum carvi L. (Apiaceae) and L. 
angustifolia EO. Citrus aurantium var. amara L. (Rutaceae) revealed lower 
antibacterial potency but showed likewise selectivity. Therefore, these EOs could be 
used for the treatment of dysbiosis without impairing the growth of salutary 
bacteria.
[67]
 
 
In the two following mentioned studies it becomes aware that the extent of the 
antimicrobial activity is among others dependant on the pH-level and the 
composition of the food
[68, 69]
: 
 
The qualification of several EOs as food preservatives was evaluated using four 
food-borne bacteria strains. Especially useful seemed to be the combination of O. 
vulgare (carvacrol 68.5%) with Origanum majorana L. (Lamiaceae) (4-thujanol 
36.2%), T. vulgaris (thymol 52.9%, p-cymene 34.0%) or with O. basilicum (linalool 
42.3%, estragole 26.9%) exhibiting an additive effect against B. cereus, P. 
aeruginosa and E. coli. The growth of L. monocytogenes was additively impaired by 
using blends of O. majorana or T. vulgaris with Rosmarinus officinalis L. 
(Lamiaceae) (eucalyptol 39.6%, camphor 19.0%), Salvia triloba L. (Lamiaceae) 
(eucalyptol 42.0%, camphor 12.0%) or O. basilicum. The strength of activity was 
influenced by the pH level and the food ingredients. Therefore, the conclusion could 
be drawn that a low pH level of about 5 and high protein content in the food supports 
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the inhibitory properties of the used EOs whereas carbohydrates and fat diminish 
it.
[68]
 
 
The antimicrobial activity against food-related bacteria was observed using the EOs 
of Melissa officinalis L. (Lamiaceae), O. majorana, O. vulgare and T. vulgaris. 
Three different media were established which were based on meat, milk and salad. 
The Listeria strains were found to be more susceptible than Lactobacillus, 
Enterobacter and Pseudomonas strains. O. vulgare and T. vulgaris – the two most 
efficient EOs - showed additive effects when used in combination. The EOs obtained 
the strongest antimicrobial activity in food with high pH level and protein content.
[69]
 
 
The organoleptic changes which are associated with the application of EOs as food-
preservatives in a high enough concentration to avoid the bacterial growth can 
represent a problem which could be solved by using aromas
[70]
 or additional 
measures to extent the shelf life of food products, such as refrigeration
[53]
: 
 
The antimicrobial effect of several substances which were found in EOs was 
investigated using the Gram-positive bacteria B. cereus, E. faecalis, L. 
monocytogenes and S. aureus. Moreover, the inhibitory activity against Gram-
negative bacteria (E. coli, Salmonella choleraesuis, Y. enterocolitica), yeasts (C. 
albicans, Zygosaccharomyces rouxii, Debaryomyces hansenii) and fungi was 
observed. Carvacrol, cinnamaldehyde and thymol displayed the strongest 
antimicrobial activity. EOs can influence the taste of packaged food in an 
unfavourable way. That is why the combination of these substances with aromas 
(banana, vanilla, strawberry) was examined. Organoleptic tests revealed that all of 
them could be used in combination with vanilla, but not with banana. Only the 
combination of strawberry aroma with thymol resulted in an organoleptic acceptable 
taste.
[70]
 
 
In an experiment with minced meat the bacteriostatic activity of the EOs of S. 
officinalis and S. molle was noticed against Salmonella anatum and S. enteritidis at 
concentrations of 1.5% using S. officinalis EO and 2.0% using S. molle. 
Unfortunately, the taste was impaired at these concentrations. That is why the 
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combination of these EOs in lower concentrations with NaCl and storage at low 
temperatures was detected to be more useful.
[53]
 
 
Sinapis alba L. (Brassicaceae) EO which was isolated from the seeds contained 
phenethyl isothiocyanate as active agent. This lead molecule was obtained by high 
performance liquid chromatography (HPLC) and silica gel column chromatography 
and subsequently subjected to chemical modifications. Paper disk diffusion assays 
were performed in order to investigate the effect on the following intestinal bacteria: 
E. coli, C. difficile, C. perfringens, Bifidobacterium breve, B. bifidum, B. longum, L. 
acidophilus and L. casei. The EO inhibited the growth of C. difficile, C. perfringens 
and E. coli at 5 mg/disk. The same Clostridium strains were effectively inhibited at a 
dose of 1 mg/disk when phenethyl isothiocyanate was singularly used. The semi-
synthetic derivates of this molecule which contained aromatic functional groups, 
such as benzyl-, benzoyl- and phenethyl-groups revealed higher selectivity and 
higher antibacterial agency against pathogenic intestinal bacteria, such as E. coli and 
Clostridium strains.
[71]
 
 
The majority of investigated EOs was rich in non-phenolic monoterpenic compounds. 
Nevertheless, also phenolic monoterpenes, such as carvacrol
[58]
 and phenylpropanoid 
constituents (e.g. cinnamaldehyde
[64]
) contributed to the antimicrobial activity 
against food-borne pathogens. 
 
 
EOs as bio-preservatives in cosmetic industry 
 
Due to the preserving activity of EOs, these substances could also be applied for the 
preservation of cosmetic products. Since some EOs show synergistic effects in 
combination with commercially used preservatives the application of EOs makes a 
diminution of these synthetic substances possible as the two below-mentioned 
studies revealed.
[72, 73]
 
 
Patrone et al. investigated the combination of several EOs with synthetic 
preservatives which are used in cosmetic industry. Eucalyptus globosus Labill. 
(Myrtaceae) and Mentha piperita L. (Lamiaceae) EO showed synergistic activity 
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against P. aeruginosa when they were applied in combination with methylparabene. 
Moreover, synergy was noticed against S. aureus using S. officinalis, O. vulgare and 
M. piperita in combination with imidazolidinyl urea and propylparabene. These 
findings constitute a further proof of the advantages of combining EOs with common 
preservatives in cosmetic products.
[72]
 
 
The application of commercial lavender, lemon and tea tree EO in body milks was 
investigated observing the inhibition of microbial growth. The main constituents of 
the lavender oil were linalool (34.1%) and linalyl acetate (33.3%). The tee trea oil 
mainly consisted of terpinen-4-ol (41.3%) and γ-terpinene (19.1%). The most 
abundant substance in lemon oil was limonene (79.8%). The growth of the involved 
microorganisms S. aureus, P. aeruginosa, Aspergillus niger and Candida species 
was sufficiently inhibited using these EOs in combination with 0.2% of a synthetic 
preservative. Since synergy was noticed when the EOs were combined with the 
synthetic agent, the applied quantity of the synthetical component could be cut down 
about 8.5 times.
[73]
 
 
 
EOs against dental bacteria 
 
This chapter deals with the antimicrobial activity of EOs against dental bacteria - 
especially against the tooth-decay causing bacteria Streptococcus pyogenes and 
Streptococcus mutans. EOs are capable of inhibiting the growth of these bacteria as 
well as the formation of biofilms. In various cases the potency of chlorohexidine was 
found to be even lower than the efficacy of the EOs.
[74]
 Therefore, the application of 
EOs is recommended in products which prevent caries.
[75]
 
 
effective against EO main constituents test method Ref. 
S. mutans Achillea ligustica 
All. (Asteraceae) 
viridiflorol 
(14.5%), 
terpinen-4-ol 
(13.0%) 
MIC = 39 
g/ml 
[75]
 
S. mutans, S. 
pyogenes 
Mentha longifolia 
L. (Lamiaceae) 
(-)-menthol disk diffusion 
test, 
[76]
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microdilution 
test  
S. mutans Hyptis pectinata L. 
Poit. (Lamiaceae) 
β-caryophyllene 
(28.3%), 
caryophyllene 
oxide (28.0%) 
MIC = 200 
g/ml 
[77]
 
Aggregatibacter 
actinomycetemc
omitans, 
Fusobacterium 
nucleatum, 
Parvimonas 
micra, 
Porphyromonas 
gingivalis, 
Prevotella 
intermedia, 
Prevotella 
nigrescens, 
Tannerella 
forsythia 
Satureja hortensis 
L. (Lamiaceae) 
carvacrol (86.6%) MICs < 0.125 
l/ml 
[78]
 
 
Table 5: EOs against dental bacteria 
 
The antimicrobial activities of R. officinalis EO, M. piperita EO and chlorohexidine 
were compared to each other using the tooth-decay causing bacteria S. pyogenes and 
S. mutans. R. officinalis EO whose main constituents were piperitone (23.7%), α-
pinene (14.9%) and linalool (14.9%) obtained MBC of 2000 ppm against S. mutans 
and 4000 ppm against S. pyogenes. Chlorohexidine showed MICs of 8000 and 1000 
ppm. M. piperita EO which mainly comprised α-terpinene (19.7%) and piperitenone 
oxide (19.3%), but also trans-carveol (14.5%) and isomenthone (10.3%) showed 
MBCs of 6000 ppm against S. mutans and 1000 ppm against S. pyogenes. The 
decimal reduction times (D-values) of the EOs were lower than that of 
chlorohexidine with 2.8 min against S. mutans. The lowest D-value against S. 
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pyogenes and the highest anti-biofilm activity was achieved by application of M. 
piperita EO. Hence, the EOs displayed even higher activity than chlorohexidine.
[74]
 
Further in-vitro as well as in-vivo experiments verified the high antibacterial activity 
of M. piperita EO against the plaque-causing bacteria S. pyogenes and S. mutans. 
Also thereby the EO showed stronger effects in preventing the formation of biofilms 
and keeping the number of bacteria in the mouth low in comparison to 
chlorohexidine.
[79]
 
 
A similar study was conducted comparing the anti-biofilm activity of Eucalyptus 
camaldulensis Dehnh. var. obtuse (Myrtaceae) EO and Mentha spicata L. 
(Lamiaceae) EO. The MBC values of both oils turned out to be 2 mg/ml against S. 
pyogenes and 4 mg/ml against S. mutans. An in-vivo experiment proved the ability of 
preventing biofilm formation. The principal constituents of M. spicata EO were 
detected to be limonene (48.0%) and piperitone (20.3%). E. camaldulensis EO 
comprised 1,8-cineole (64.0%) and α-pinene (9.6%). E. camaldulensis EO reached a 
D-value of 2.8 min against S. mutans using the MBC, so did M. spicata EO. For 
comparison only, the D-value of chlorohexidine (2%) was 12.8 min. Only 3.6 min 
were measured against S. pyogenes using E. camaldulensis EO, whereas the D-value 
was 4.3 min using M. spicata EO.
[80]
 
 
It becomes quite obvious that Mentha species play an important role in inhibiting the 
growth of tooth-decay causing bacteria. Although the composition of the individual 
species differ from each other all of them achieved remarkable results in impairing 
the microbial growth of periodontal pathogens. 
 
 
EOs against diverse human pathogens 
 
effective against EO main constituents test method Ref. 
Cryptococcus 
neoformans; K. 
pneumoniae 
Abies 
holophylla 
Maxim. 
(Pinaceae) 
bicyclo[2.2.1] 
heptan-2-ol 
(28.1%) 
MIC = 0.5 
mg/ml; MIC = 
10.9 mg/ml 
[81]
 
Candida Abies koreana bornyl ester MIC = 0.5 
[81]
 
 27 
glabrata; K. 
pneumoniae; B. 
subtilis, E. coli 
E.H.Wilson 
(Pinaceae) 
(41.8%) mg/ml; MIC = 
5.5 mg/ml; 
MIC = 10.9 
mg/ml 
B. subtilis, S. 
aureus 
Ageratum 
conyzoides L. 
(Asteraceae) 
precocene I 
(52.2%), 
caryophyllene 
(26.2%) 
disk diffusion 
tests 
[82]
 
E. coli, K. 
pneumoniae 
Anaphalis 
nubigena DC. 
var. 
monocephala 
(DC.) C. B. 
Clarke 
(Asteraceae) 
-guaiene (12.3%), 
-muurolene 
(10.4%) 
MIC = 125 
g/ml, MIC = 
500 g/ml 
[83]
 
S. aureus, S. 
epidermidis, C. 
albicans, C. 
neoformans 
Artemisia 
absinthium L. 
(Asteraceae) 
trans-sabinyl 
acetate (26.4%), 
myrcene (10.8%), 
trans-thujone 
(10.1%) 
agar diffusion 
tests 
[84]
 
B. subtilis, K. 
pneumoniae, 
Bacillus mycoides 
Ballota nigra L. 
(Lamiaceae) 
p-vinylguiacol 
(9.2%), borneol 
(7.5%) 
disk diffusion 
test, dilution 
test 
[85]
 
Streptococcus 
agalactiae, S. 
pyogenes 
Bupleurum 
marginatum 
Wall. ex DC. 
(Apiaceae) 
tridecane (13.2%), 
undecane (10.4%) 
MIC = 0.125 
to 4.00 mg/ml 
[86]
 
S. aureus, 
Streptococcus 
faecalis 
Callistemon 
citrinus (Curtis) 
Skeels 
(Myrtaceae) 
1,8-cineole (61.2%)  disk diffusion 
test, broth 
microdilution 
test 
[87]
 
S. aureus, S. 
faecalis, B. 
cereus, Serratia 
Callistemon 
viminalis 
(Gaertn.) G.Don 
1,8-cineole (83.2%)  disk diffusion 
test, broth 
microdilution 
[87]
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marcescens (Myrtaceae) test 
Clostridium 
bifermentas, 
Enterococcus 
faecium, 
Enterococcus 
hirae, 
Streptococcus 
salivarius subsp. 
thermophilus 
Cannabis sativa 
L. 
(Cannabaceae) 
myrcene, -pinene, 
-caryophyllene 
broth dilution 
test 
[88]
 
Staphylococcus 
simulans, 
Staphylococcus 
lugdunensis, S. 
aureus, S. 
epidermitis, 
Candida 
tropicalis 
Carum 
montanum 
(Coss. et Dur.) 
Benth. et Hook. 
(Apiaceae) 
nothoapiole 
(62.8%) 
diffusion test 
[89]
 
B. subtilis, C. 
albicans 
Chamaecyparis 
nootkatensis (D. 
Don) Spach. 
(Cupressaceae) 
limonene (53.2%) diffusion test 
[90]
 
E. faecalis, S. 
aureus 
Cordia 
verbenacea 
D.C. 
(Boraginaceae) 
tricyclene (23.9%), 
bicyclogermacrene 
(11.7%) 
MIC = 200 
g/ml, MIC = 
170 g/ml 
[91]
 
S. aureus, 
Pasteurella 
multocida 
Dodecadenia 
grandiflora 
Nees 
(Lauraceae) 
germacrene D 
(26.0%), 
furanodiene 
(13.7%) 
disk diffusion 
test, dilution 
test 
[51]
 
B. cereus, B. 
subtilis, 
Micrococcus 
luteus, S. aureus 
Enterolobium 
contortisiliquu
m (Vell.) 
Morong 
carvone  
[92]
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(Fabaceae) 
E. coli, S. aureus Erigeron 
mucronatus DC 
(Asteraceae) 
caryophyllene 
(11.4%), limonene 
(10.3%) 
Disk diffusion 
test 
[93]
 
P. aeruginosa Eugenia 
beaurepaireana 
(Kiaersk.) D. 
Legrand 
(Myrtaceae) 
-caryophyllene 
(8.0%), 
bicyclogermacrene 
(7.2%) 
MIC = 278.3 
g/ml 
[94]
 
S. aureus Eugenia 
brasiliensis 
Lam. 
(Myrtaceae) 
spathulenol 
(12.6%), -cadinol 
(8.7%) 
MIC = 156.2 
g/ml 
[94]
 
S. aureus Eugenia 
umbelliflora 
Berg. 
(Myrtaceae) 
viridiflorol 
(17.7%), -pinene 
(13.2%) 
MIC = 119.2 
g/ml 
[94]
 
B. subtilis, S. 
aureus, S. 
mutans, E. coli, 
E. faecalis, C. 
albicans 
Ferula glauca 
L. (Apiaceae) 
leaf EO: (E)-
caryophyllene 
(24.9%), fruit EO: 
-pinene (24.2%), 
root EO: (E)--
farnesene (10.0%), 
elemicin (9.0%), 
flower EO: 
germacrene D 
(14.2%), myrcene 
(13.6%) 
MIC = 38 to 
1250 g/ml 
[95]
 
S. aureus, E. coli, 
S. enterica 
enterica, Shigella 
flexneri, P. 
multocida  
Hedychium 
aurantiacum 
Wall. ex Roscoe 
(Zingiberaceae) 
terpinen-4-ol disk diffusion 
test, MIC = 
2.0 – 15.6 
l/ml 
[96]
 
S. aureus, E. coli, Hedychium trans-meta-mentha- disk diffusion 
[96]
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S. enterica 
enterica, Shigella 
flexneri, P. 
multocida 
coronarium 
J.König 
(Zingiberaceae) 
2,8-diene, linalool test, MIC = 
7.8 – 31.3 
l/ml 
S. aureus, E. coli, 
S. enterica 
enterica, Shigella 
flexneri, P. 
multocida 
Hedychium 
ellipticum Sm. 
(Zingiberaceae) 
1,8-cineole, 
sabinene  
disk diffusion 
test, MIC = 
7.8 – 31.3 
l/ml 
[96]
 
S. aureus Hymenocrater 
longiflorus 
Benth. 
(Lamiaceae) 
δ-cadinol (18.5%), 
α-pinene (10.2%), 
p-menth-1-en-8-ol 
(9.8%) 
MIC = 120 
g/ml 
[39]
 
B. subtilis, S. 
aureus 
Hypericum 
hirsutum L. 
(Guttiferae) 
(E,E)--farnesene 
(7.0–13.8%) and 
(E)--farnesene 
(7.2–9.4%) 
broth 
microdilution 
test 
[97]
 
B. subtilis, S. 
aureus 
Hypericum 
richeri Vill. 
subsp. richeri 
(Guttiferae) 
germacrene D 
(26.9%) 
broth 
microdilution 
test 
[97]
 
B. subtilis, S. 
aureus 
Hypericum 
tetrapterum Fr. 
(Guttiferae) 
-copaene (12.7%), 
-longipinene 
(8.1%) 
broth 
microdilution 
test 
[97]
 
E. faecium, B. 
cereus, S. aureus, 
C. albicans, 
Candida 
tropicalis, C. 
glabrata, 
Candida 
parapsilosis 
Inula helenium 
L. (Asteraceae) 
alantolactone, 
isoalantolactone 
MIC = 0.009 
to 0.6 mg/ml 
[98]
 
B. subtilis, B. 
cereus, S. aureus, 
Juniperus 
phoenicea L. 
-pinene  agar diffusion 
test 
[99]
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L. 
monocytogenes, 
P. aeruginosa 
(Cupressaceae) 
[100]
 
S. agalactiae, S. 
pyogenes  
K. 
longipedunculat
a 
-cadinene (21.8%) MIC = 60 
g/ml 
[15]
 
S. aureus, S. 
epidermidis, M. 
luteus 
Laserpitium 
zernyi Hayek 
(Apiaceae) 
-pinene (31.6%), 
-bisabolol 
(30.9%) 
microdilution 
test 
[101]
 
S. aureus, S. 
enterica enterica, 
P. multocida 
Lindera 
pulcherrima 
(Nees) Hook. f. 
(Lauraceae) 
furanodienone 
(46.6%) 
disk diffusion 
test, dilution 
test 
[51]
 
S. aureus; E. 
faecalis; 
Citrobacter 
freundii, 
Staphylococcus 
saprophyticus 
Lindera 
strychnifolia 
(Sieb. & Zucc.) 
Fern. 
(Lauraceae)  
root EO: 
zerumbone 
(26.7%), 
leaf EO: 
sesquithuriferol 
(35.9%) 
MIC = 0.01 
mg/ml; MIC = 
0.02 mg/ml; 
MIC = 0.78 
mg/ml  
[102]
 
B. subtilis, E. 
faecalis, E. coli, 
P. aeruginosa, S. 
aureus, Monilia 
albicans 
Litsea cubeba 
(Lour.) Pers. 
(Lauraceae) 
neral, -terpinene, 
-phellandrene 
disk diffusion 
test, 
microbroth 
dilution test, 
MIC = 100 to 
1000 g/ml 
[103]
 
K. pneumoniae, 
L. 
monocytogenes, 
C. albicans 
Mentha 
longifolia L. 
(Lamiaceae) 
pulegone (54.4%) Diffusion test 
[104]
 
K. pneumoniae, 
L. 
monocytogenes, 
C. albicans 
Mentha viridis 
L. (Lamiaceae) 
carvone (50.5%) Diffusion test 
[104]
 
B. subtilis; S. Metasequioa 2-butaneone MIC = 125 
[105]
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aureus, P. 
aeruginosa; E. 
coli 
glyptostroboide
s Miki ex Hu. 
(Taxodiaceae) 
(30.6%) g/ml; MIC = 
250 g/ml; 
MIC = 500 
g/ml 
S. aureus Momordica 
charantia L. 
(Cucurbitaceae) 
trans-nerolidol 
(61.6%) 
MIC = 125 
g/ml 
[106]
 
E. faecalis, S. 
aureus, E. coli, P. 
aeruginosa, K. 
pneumoniae 
Monticalia 
andicola Turcz. 
(Asteraceae) 
-pinene (19.6%), 
-pinene (10.5%) 
MIC = 10 to 
150 g/ml 
[107]
 
P. multocida Neolitsea 
pallens (D. 
Don) 
Momiyama & 
Hara 
(Lauraceae) 
furanogermenone 
(59.5%) 
disk diffusion 
test, dilution 
test 
[51]
 
K. pneumoniae, S. 
aureus, B. 
macerans; S. 
epidermidis, S. 
pyogenes, B. 
subtilis; 
Burkholderia 
cepacia, Brucella 
abortus, E. coli, 
C. albicans 
Nepeta cataria 
L. (Lamiaceae) 
4a,7,7a-
nepetalactone 
(70.4%) 
MIC = 15.62 
g/ml;  
MIC = 62.5 
g/ml;  
MICs = 125 
g/ml 
[108]
 
B. subtilis, S. 
aureus, C. 
albicans 
Ocimum 
forskolei Benth 
(Lamiaceae) 
estragole diffusion test 
[109]
 
 
P. mirabilis, P. 
aeruginosa, S. 
aureus, E. coli 
Ocimum 
gratissimum L. 
(Lamiaceae) 
eugenol (68.8% - 
74.1%) 
disk diffusion 
test 
[110]
 
Proteus vulgaris, Origanum carvacrol disk diffusion 
[111]
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S. typhimurium, 
E. cloacae, S. 
aureus, E. coli, K. 
pneumoniae, 
Corynebacterium 
diphtheriae, C. 
albicans 
acutidens 
(Hand.-Mazz.) 
Ietswaart 
(Lamiaceae) 
test 
[112]
 
 
S. aureus; P. 
aeruginosa 
Origanum 
compactum 
Benth. 
(Lamiaceae) 
carvacrol (37.8%), 
thymol (19.8%) 
MIC = 1% 
(v/v); MIC = 
0.031% (v/v) 
[113]
 
B. subtilis; S. 
flexneri, S. 
aureus; E. coli, K. 
pneumoniae, 
Salmonella 
choleraensius 
O. majorana terpinen-4-ol 
(30.4%) 
MIC = 0.069 
mg/ml; MIC = 
0.782 mg/ml; 
MIC = 0.920 
mg/ml 
[114]
 
B. subtilis, E. coli Pamburus 
missionis 
(Wight) 
Swingle 
(Rutaceae) 
1-tridecanol 
(38.3%), 1-
hexadecanoic acid 
(16.1%) 
MIC = 10 
mg/ml 
[115]
 
 
E. coli, P. 
multocida 
Persea duthiei 
King ex. Hook 
f. (Lauraceae) 
(E)-nerolidol 
(13.2%), limonene, 
α-pinene, β-pinene 
(10.0% each) 
disk diffusion 
test, dilution 
test 
[51]
 
S. aureus, S. 
enterica enterica 
Persea gamblei 
(King ex 
Hook.f.) 
Kosterm. 
(Lauraceae) 
β-caryophyllene 
(22.1%), γ-
gurjunene (16.8%) 
disk diffusion 
test, dilution 
test 
[51]
 
S. aureus, E. coli, 
S. enterica 
enterica 
Persea 
odoratissima 
(Nees) Kost. 
α-pinene (16.6%), 
sabinene (13.1%), 
β-caryophyllene 
disk diffusion 
test, dilution 
test 
[51]
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(Lauraceae) (10.4%) 
B. cereus, B. 
subtilis, S. 
aureus, E. coli, P. 
aeruginosa, S. 
typhi, C. albicans, 
C. tropicalis 
Phyllanthus 
emblica L. 
(Phyllanthaceae
) 
-caryophyllene, -
bourbonene 
MIC = 100 to 
1000 g/ml 
[116]
 
S. aureus, 
Enterococcus 
hirae; P. 
aeruginosa, E. 
coli; C. albicans 
Pituranthos 
chloranthus 
Benth. and 
Hook. 
(Apiaceae) 
terpinen-4-ol 
(30.3%) 
MIC = 1.875 
mg/l; MICs = 
3.75 mg/l; 
MIC = 7.5 
mg/l 
[117]
 
S. aureus, M. 
luteus, S. 
typhimurium; S. 
epidermidis 
Rhaponticum 
acaule DC 
(Asteraceae) 
methyl eugenol, 
epi-13-manool 
disk diffusion 
test, MIC = 
500 μg/ml; 
MIC = 800 
μg/ml 
[118]
 
S. aureus; L. 
monocytogenes, 
C. albicans; E. 
faecalis, S. 
pyogenes 
Rhaponticum 
carthamoides 
(Willd.) Iljin 
(Asteraceae) 
13-norcypera-
1(5),11(12)-diene 
(22.6%), aplotaxene 
(21.2%)  
MIC = 32 
g/ml; MIC = 
128 g/ml; 
MIC = 256 
g/ml 
[119]
 
S. aureus, 
Streptococcus 
pneumoniae, 
Shigella spp, E. 
faecalis 
Ridolfia 
segetum (L.) 
Moris 
(Apiaceae) 
dillapiole (47.4%)  MIC = 1.25 
mg/ml 
[120]
 
B. subtilis, 
Chromobacterium 
violaceum, E. 
coli; S. aureus, 
Erwinia 
carotovora 
Rosa 
damascena 
Mill. 
(Rosaceae) 
citronellol (35.2%), 
geraniol (22.2%) 
MIC = 0.25% 
(v/v); 
 
MIC = 0.5% 
(v/v) 
[121]
 
E. coli, K. R. officinalis 1,8-cineole, MIC = 1.25 to 
[122]
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pneumoniae, S. 
aureus, B. 
subtilis, B. 
cereus, S. 
epidermidis, S. 
faecalis 
var. typicus and 
var. 
troglodytorum 
camphor 
 
10 μl/ml 
A. lwoffii; C. 
perfringens, S. 
pneumoniae 
Salvia 
aramiensis 
Rech. fil. 
(Lamiaceae) 
1,8-cineole (46.0%) disk diffusion 
test, MIC = 
4.5 mg/ml; 
MIC = 18 
mg/ml 
[123]
 
A. lwoffii Salvia aucheri 
var. aucheri 
Boiss. 
(Lamiaceae) 
1,8-cineole 
(30.5%), camphor 
(21.3%) 
disk diffusion 
test, broth 
microdilution 
test 
[123]
 
B. cereus, B. 
subtilis, S. 
aureus, S. 
epidermidis, S. 
faecalis; P. 
vulgaris, S. typhi 
Salvia bracteata 
Banks et Sol. 
(Lamiaceae) 
caryophyllene 
oxide (16.6%) 
MIC = 50 
g/ml; 
 
 
MIC = 100 
g/ml 
[124]
 
B. subtilis, E. 
faecalis, S. 
aureus, S. 
epidermidis E. 
coli, P. 
aeruginosa, K. 
pneumoniae 
Salvia 
chloroleuca 
Rech. F. & 
Aell. 
(Lamiaceae) 
-pinene (10.6%), 
1,8-cineole, -
caryophyllene, -
pinene (9.0% each) 
and carvacrol 
(7.9%) 
disk diffusion 
test, dilution 
test 
[125]
 
S. aureus,  
S. epidermidis 
Salvia 
eremophila 
Boiss. 
(Lamiaceae) 
borneol (21.8%), -
pinene (18.8%), 
bornyl acetate 
(18.7%) 
MIC = 7.8 
g/ml, MIC = 
125 g/ml 
[126]
 
A. lwoffii Salvia pilifera 
Benth. 
-thujene (36.1%) disk diffusion 
test, broth 
[123]
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(Lamiaceae) microdilution 
test 
B. cereus, B. 
subtilis, S. 
aureus, S. 
epidermidis, S. 
faecalis; 
P. vulgaris, P. 
aeruginosa 
Salvia rubifolia 
Boiss. 
(Lamiaceae) 
-muurolene 
(11.8%) 
MIC = 50 
g/ml; 
 
 
 
 
MIC = 100 
g/ml 
[124]
 
B. cereus, E. 
faecalis, 
bark EO: also P. 
mirabilis 
Santiria trimera 
(Oliv.) Aubrév. 
(Burseraceae) 
leaf EO: -
humulene (34.6%), 
bark EO: -pinene 
(51.5%) 
agar disc 
diffusion  test, 
broth 
microdilution 
test 
[127]
 
MRSA, P. 
vulgaris, S. 
typhimurium, C. 
albicans, C. 
tropicalis 
Satureja 
cuneifolia Ten. 
(Lamiaceae) 
thyme MIC = 62.5 to 
500 g/ml 
[128]
 
 B. subtilis, S. 
aureus, E. 
faecalis, K. 
pneumoniae, E. 
coli, P. 
aeruginosa 
Satureja 
spicigera (C. 
Koch) Boiss. 
(Lamiaceae) 
carvacrol (53.7%), 
thymol (36.0%) 
disk diffusion 
test 
[129]
 
S. aureus, P. 
aeruginosa; C. 
albicans 
Schinus 
terebinthifolius 
Raddi. 
(Anacardiaceae) 
cis--terpineol 
(17.9%), (E)-
caryophyllene 
(17.6%) 
MIC = 0.80 
mg/ml; MIC = 
0.85 mg/ml 
[130]
 
B. subtilis, P. 
aeruginosa 
Stachys cretica 
L. subsp. 
smyrnaea Rech. 
fil. (Lamiaceae) 
trans--
caryophyllene 
(51.0%), 
germacrene D 
disk diffusion 
test 
[131]
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(32.8%) 
B. subtilis, 
Bacillus pumulis, 
E. coli, E. 
faecalis, K. 
pneumoniae, S. 
aureus, S. 
epidermidis, P. 
aeruginosa, C. 
albicans  
Tanacetum 
balsamita L. 
subsp. 
balsamita 
(Asteraceae) 
carvone (51.0%), -
thujone (20.8%) 
disk diffusion 
test, dilution 
test 
[132]
 
B. subtilis, S. 
epidermidis, S. 
aureus, S. faecalis 
Teucrium 
divaricatum 
Sieb. ssp. 
villosum 
(Celak.) Rech. 
fil. (Lamiacae) 
(E)-caryophyllene 
(30.1%) 
MIC = 25 to 
100 μg/ml 
[133]
 
A. lwoffii, S. 
pyogenes, E. coli, 
Listeria species, 
C. albicans, C. 
parapsilosis, 
Candida krusei 
Thymbra 
spicata L. 
(Lamiaceae) 
carvacrol (60.4%) disk diffusion 
test,  dilution 
test 
[134]
 
 
Table 6: EOs against human pathogens 
 
Since the chemical composition of EOs can change according to the growing place 
and the point of time at which the plants are collected, the antimicrobial activity can 
be influenced by these parameters. That is why the EO of S. cuneifolia which was 
isolated of plants in the post-flowering stage presented lower MIC values than the 
EOs of pre-flowering and flowering stage.
[128]
 In another study the chemical 
composition of H. spicatum Buch.-Ham. (Zingiberaceae) was noticed to be 
dependent on the collection area. Therefore, some samples contained primary 
sabinene and terpinen-4-ol whereas others mainly obtained 10-epi--eudesmol and 
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1,8-cineole. Both samples showed activity against S. aureus, P. multocida and E. 
coli.
[96]
 
 
Beside of exerting bacteriostatic and bactericidal effects EOs are also capable of 
impairing the development of capsules
[135]
 and spores
[136]
. 
 
Cuminum cyminum L. (Apiaceae) is on the one hand a popular spice on the other 
hand it is traditionally applied for its astringent and carminative effects. The EO of 
this plant was investigated presenting a high content of α-pinene (29.1%), limonene 
(21.5%) and 1,8-cineole (17.9%). During in-vitro tests S. aureus, Streptococcus 
faecalis and E. coli appeared to be the most susceptible pathogens whereas K. 
pneumoniae was tolerant to the EO. Diverse chemotypes of this plant exist.
[137]
 This 
explains why the seed EO of C. cyminum mainly comprised cumin aldehyde (25.2%) 
and γ-terpinene (19%) in another study. This oil exerted antibacterial activity against 
K. pneumoniae demonstrated by MIC and MBC results in the range from 0.8 to 
3.5 μg/ml. At concentrations lower than the MIC the formation of capsules was 
prevented and the function of urease was impaired.
[135]
 
 
The development of bacterial spores of B. subtilis was impaired by various EOs of 
which Elettaria cardamomum (L.) Maton (Zingiberaceae) and M. alternifolia 
showed the strongest inhibitory impact. The main compounds of M. alternifolia EO 
(terpinen-4-ol, 38.0% of the EO) and those of E. cardamomum (α-terpinyl acetate 
46.0% and 1,8-cineole 34.0%) possessed sporicidal activity, but not in such extent as 
the whole EO. This indicated the potential existence of synergistic interactions 
among the individual constituents and the importance of substances which were 
represented in lower levels.
[136]
 Despite of the fact that M. alternifolia EO exerts 
strong inhibitory activity against microbes, some bacteria are nevertheless capable of 
developing protection measures against it. A study proved that some P. aeruginosa 
strains obtain special pumps (MexAB-OprM pumps) which induce resistance 
towards monoterpenes which occur in M. alternifolia EO such as terpinen-4-ol, -
terpineol and 1,8-cineole by ejecting them.
[138]
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Various studies show that the extent of antimicrobial activity and the mode of action 
are dependent on the additive and synergistic or even antagonistic effects of the 
individual constituents.
[136, 139, 140]
 
 
The additive interactions of two T. vulgaris chemotypes were observed involving the 
cravacrol and the linalool cemotype. The most abundant substances in the EO of 
these plants were carvacrol, linalool and thymol. Additive antimicrobial activity was 
noticed when these two oils were combined, when their isolated monosubstances 
linalool and carvacrol were used in combination or linalool with thymol. When using 
the monosubstances in combinations as previously described they exhibited a partial 
synergistic effect against K. pneumoniae. The conclusion can be drawn that the 
antimicrobial effect of T. vulgaris EO correlates with the additive effects between the 
single components.
[139]
 
 
When combining farnesol with geraniol or geranylgeraniol the mechanism of action 
against S. aureus was affected in comparison to using farnesol singularly. Therefore, 
the damaging effect of farnesol to the bacterial cell membrane was reduced in 
combinations with geraniol, but nevertheless cell proliferation was more strongly 
impaired. Geranylgeraniol impeded both modes of action. That is why it is not 
sufficient to investigate the mode of action of the major component of an EO, since 
the mechanism of the EO is a result of the single constituents interactions.
[140]
 
 
The following study verifies that the single compounds of EOs could be used as 
starting material for the development of semi-synthetic substances which are 
characterized by stronger antimicrobial efficacy: In a study published by Pintore et al. 
the EO of R. officinalis was divided into oxygenated fractions whose main 
components were 1,8-cineole (37.6%) and bornyl acetate (21.4%) and hydrocarbon 
fractions consisting of -pinene (44.2%), camphene (24.5%) and limonene (11.7%). 
Moreover, the hydrocarbon fraction was transformed into a hydroformulated fraction. 
These three fractions and the original EO were tested using different microbes to 
determine their antibacterial activity. The highest antimicrobial effect was achieved 
against Aeromonas sobria and Candida strains. The hydroformulated fraction even 
displayed a fungicidal effect on Candida strains that were robust against the natural 
EO and the other two fractions.
[141]
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The antimicrobial activity of EOs can absolutely keep up with the bacteriostatic 
activity of synthetic active agents. Therefore, equal or even better results were 
achieved in tests involving EOs and amphotericin B
[142]
, chloroamphenicol or 
streptomycin.
[143]
 
 
The EO of Perovskia abrotanoides Karel (Lamiaceae) – a plant which is traditionally 
applied in the therapy of leishmaniasis – contained a high quantity of camphor (23%) 
and 1,8-cineole (22%) and α-pinene (12%). The most susceptible germs revealed to 
be S. aureus determined by a MIC and MBC of 8 l/ml and B. cereus with MIC and 
MBC values of 2 l/ml. The EO showed no activity against Gram-negative bacteria 
(E. coli and P. aeruginosa). The activity against C. albicans was equal to the potency 
of amphotericin B with MIC and minimal fungicidal concentration (MFC) values of 
8 l/ml. Since the EO showed antimicrobial activity, it could inhibit the 
manifestation of secondary microbial infections in leishmaniasis patients. When 
using camphor, 1,8-cineole and α-pinene against the above-mentioned 
microorganisms singularly camphor achieved the lowest MIC results of 1 or 2 l/ml 
in microbroth dilution assays, whereas 1,8-cineole showed the lowest effect.
[142]
 
 
The volatile oil obtained from the rhizomes of Zingiber officinale Rosc. 
(Zingiberaceae) primarily comprised geranial (25.9%) and -zingiberene (9.5%). 
Antimicrobial efficacy was observed against S. aureus, P. vulgaris, P. aeruginosa, K. 
pneumoniae, whereas E. coli revealed to be insensitive to the EO. The activity was 
higher than that of chloramphenicol and similar to streptomycin.
[143]
 
 
By flow cytometry the damaging effect of thymol and carvacrol to the E. coli cell 
membrane was proved. Both substances inhibited the growth of this microorganism 
using a concentration of 200 mg/l.
[144]
 
 
EOs with aldehydic or phenolic compounds exerted the strongest antimicrobial 
efficiency with MIC values lower than 2% (v/v) in a study involving thirteen 
different EOs and 65 bacteria strains. Cymbopogon citratus (DC.) Stapf (Poaceae) 
and Cinnamomum verum J.Presl (Lauraceae) bark revealed EOs with high aldehyde 
content, such as geranial, neral and cinnamaldehyde, respectively. Components of 
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the EOs rich in phenolic compounds were thymol and carvacrol in O. compactum, 
thymol in Trachyspermum ammi (L.) Sprague (Apiaceae), eugenol in Eugenia 
caryophyllus (Sprengel) Bullock & Harr. (Myrtaceae) and C. verum leaf EO. The 
growth of P. aeruginosa was most effectively inhibited by O. compactum and C. 
verum bark EO with MICs lower than 2%. M. alternifolia (terpinene-4-ol), 
Cymbopogon martinii (Roxb.) Wats. (Poaceae) (geraniol) and L. angustifolia (linalyl 
actetate, linalool) EOs obtained a high amount of alcohols and therefore fluctuating 
antibacterial efficacy. Hydrocarbons (such as limonene) and the bicyclic ether 1,8-
cineole which were present in C. sinensis, E. globulus and Melaleuca cajeputii 
Powell (Myrtaceae) showed weaker antibacterial activity with MICs higher than 10% 
(v/v).
[145]
 
 
First and foremost plants of the Lamiaceae family exhibited high antimicrobial 
activity against a wide range of Gram-positive and Gram-negative bacteria. 
Especially different Origanum, Salvia and Mentha species which are representatives 
of this family achieved significant results in antimicrobial tests. In general, the most 
frequently occurring substances were identified as the sesquiterpenes caryophyllene 
and germacrene D as well as the phenolic monocyclic monoterpenes carvacrol and 
thymol. Moreover, the monocyclic monoterpenes 1,8-cineole, terpinen-4-ol and the 
bicyclic monoterpene -pinene were often detected in the EOs. 
 
 
EOs against Borrelia burgdorferi 
 
B. burgdorferi is a bacterium belonging to the class of spirochetes which is spread by 
ticks and causes the lyme disease in humans.
[146]
 
The EO of Cistus creticus L. (Cistaceae) was subjected to GC/MS analysis and to in-
vitro tests to investigate its impact on the growth of B. burgdorferi as a consequence 
to the fact that borreliosis patients observed reduced pain after intake of C. creticus 
leaf products. It turned out that the EO decreased the quantity of these germs to 2% 
used at a concentration of 0.02%. GC/MS screenings revealed the presence of 
carvacrol and various diterpenes of the labdane-type including manoyl oxide. These 
substances are proved to have antimicrobial properties.
[147]
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EOs against nocardiform actinomycetes 
 
a) EOs against Mycobacteria 
 
Mycobacterium tuberculosis is a Gram-positive pathogen which is responsible for 
the emergence of tuberculosis. Also in this case drug-resistant strains were identified 
which impede an effective cure and indicate alternative active agents.
[148]
 
 
effective against EO main constituents test method Ref. 
M. tuberculosis Achyrocline 
alata (Kunth) 
DC. 
(Asteraceae) 
thymol (24.0%) MIC = 62.5 
g/ml 
[149]
 
M. tuberculosis Anemia 
tomentosa 
(Sav.) var. 
anthriscifolia 
(Schrad).  
(Anemiaceae) 
(-)-epi-
presilphiperfolan-1-
ol (30.6%), 
silphiperfol-6-ene 
(14.7%) 
MIC = 100 
g/ml 
[150]
 
M. tuberculosis Lantana fucata 
Lindl. 
(Verbenaceae) 
-elemene (27.1%), 
germacrene D 
(11.6%), (E)-
caryophyllene 
(7.7%) 
MIC = 100 
g/ml 
[151]
 
M. tuberculosis Lantana trifolia 
L. 
(Verbenaceae) 
germacrene D 
(45.1%), (E)-
caryophyllene 
(12.8%), 
bicyclogermacrene 
(12.7%) 
MIC = 80 
g/ml  
[151]
 
M. tuberculosis Swinglea 
glutinosa Merr. 
(Rutaceae) 
-pinene (49.6%) MIC = 100 
g/ml 
[149]
 
Mycobacterium  trans- MIC = 25.9 
[152]
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avium subsp. 
paratuberculosis 
cinnamaldehyde g/ml 
M. avium subsp. 
paratuberculosis 
 carvacrol MIC = 72.2 
g/ml 
[152]
 
M. avium subsp. 
paratuberculosis 
 2,5-dihydroxybenz- 
aldehyde 
MIC = 74 
g/ml 
[152]
 
M. avium subsp. 
paratuberculosis 
 2-hydroxy-5-
methoxybenz-
aldehyde   
MIC = 90.4 
g/ml 
[152]
 
 
Table 7: EOs against mycobacteria 
 
The growth of M. tuberculosis was most effectively inhibited by the application of an 
EO characterized by a high amount of the phenolic monoterpene thymol
[149]
, but also 
EOs with non-phenolic monoterpenes (such as -pinene[149]) and sesquiterpenes (e.g. 
germacrene D
[151]
) obtained low MIC results. 
 
b) EOs against Nocardia asteroides  
 
Especially immunosuppressed patients are susceptible to N. asteroides infections 
which are usually generated by inhalation of the germs. In most cases these bacteria 
lead to pulmonary diseases.
[153]
 In the two below-mentioned studies a strong 
antimicrobial activity of the EOs was assessed against N. asteroides. 
 
The most prevalent substance in Daucus crinitus Desf. (Apiaceae) EO revealed to be 
a rare phenylpropanoid, namely isochavicol isobutyrate (39.0%). Also isochavicol 
propionate – a molecule which has never been before found in nature - was detected 
in a low quantity. The antimicrobial activity against several bacteria and fungi was 
examined presenting the highest activity against N. asteroides with a MIC value of 
310 g/ml. Moreover, moderate activity was noticed against Gram-positive bacteria 
such as S. aureus and against C. albicans. Gram-negative bacteria strains (K. 
pneumoniae and S. enteriditis) were found to be tolerant to the EO. Isochavicol 
isobutyrate showed no significant inhibiting effect in the disk diffusion test. This 
leads to the conclusion that other components of the EO might be responsible for its 
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agency, such as α-pinene (9.9%), β-caryophyllene (5.4%) or myrcene (3.4%). 
Nevertheless, isochavicol derivatives showed noteworthy MIC results in the range 
from 16 to 61 g/ml against N. asteroides in the microdilution test.[154] 
 
The EO of Bupleurum plantagineum Desf. (Apiaceae) and Bupleurum montanum 
Coss & Dur. (Apiaceae) was isolated from the aerial plant parts and afterwards 
submitted to GC/MS analysis. The oil of B. plantagineum was characterized by a 
high amount of -pinene (31.9%), myrcene (24.8%) and cis-chrysanthenyl acetate 
(28.2%). The main compound of B. montanum EO was megastigma-4,6-(E),8(2)-
triene (25.3%). N. asteroides as well as E. faecalis and S. aureus were assessed to be 
the most vulnerable pathogens.
[155]
 
 
c) EOs against Rhodococcus equi 
 
R. equi was primarily detected as pneumonia-causing bacterium in foals, but it turned 
out that these pathogens can likewise infect humans. Also in this case especially 
immunocompromised persons are infected.
[156]
 
 
Costa et al. investigated the chemical composition and the antibacterial activity of the 
leaf EOs isolated from three Guatteriopsis species collected in Brazil. Caryophyllene 
oxide (69.3%) was identified as the predominant substance in G. blepharophylla 
Mart. (Annonaceae) EO whereas -pinene (38.2%), -pinene (30.8%) and (E)-
caryophyllene (20.6%) were prevalent in G. hispida R.E.Fr. (Annonaceae) EO. The 
strongest antibacterial agency was shown by G. friesiana W. A. Rodrigues 
(Annonaceae) EO whose major constituents were -eudesmol (51.6%) and -
eudesmol (23.7%). All involved bacteria were inhibited by this EO, among others B. 
subtilis (MIC of 60 g/ml), S. epidermidis and E. hirae with a MIC result of 100 
g/ml. R. equi was ascertained to be the most vulnerable pathogen with MICs of 50 
g/ml no matter which oil was applied. In tests using the individual components of 
the EOs the eudesmol molecules showed the highest antimicrobial effect, but did not 
achieve as high activity as the EO.
[157]
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EOs as water disinfectants 
 
Legionella pneumophila is a pathogen which can lead to Legionnaire's disease, a life-
threatening infection of the respiratory system. The presence of these bacteria was 
noticed in air conditioning systems and water pipes.
[158]
 The following studies 
demonstrate that EOs could be used to impair the growth of these germs, e.g. in 
pharmaceutical aerosols or for the maintenance of water quality.
[159]
 
 
One of these bacteriostatic EOs was isolated from M. alternifolia which comprised a 
high content of terpinen-4-ol (42.4%) and led to a remarkable growth inhibition by 
using MICs between 0.125 and 0.5% (v/v). 
[159]
 
 
In a further study the potential use of Cinnamomum osmophloeum Kaneh (Lauraceae) 
EO whose lead molecule was by far cinnamaldehyde (91.3%) as water disinfectant 
was investigated. The EO turned out to have significant antimicrobial activity against 
L. pneumophila. Its activity was found to be even higher at basic pH levels. Thus, it 
could be used in spas for disinfection of water which obtains a basic pH level, 
especially because the effectiveness of chlorine is diminished in alkaline 
surroundings.
[160]
 Moreover, it could be applied for the prevention of L. pneumophila 
growth in the water of hot water pipes.
[161]
 
 
Thymus capitatus (L.) Hoffmanns. & Link (Lamiaceae) EO which is rich in carvacrol 
and thymol presented high potential as water disinfectant just as its single constituent 
carvacrol did. Therefore, the employment of this EO impaired the growth of coliform 
bacteria when using 94 mg of EO per litre of spoiled water. At concentrations of 468 
mg/l the number of coliforms decreased so massively that the non-existence of these 
pathogens could be verified. Moreover this condition continued for two weeks.
[162]
 
 
 
EOs as air disinfectants 
 
The EOs of Pelargonium graveolens L'Hér. (Geraniaceae) and Cymbopogon 
flexuosus (Nees ex Steud.) Will.Watson (Poaceae) were used in a mixture which 
contained geranial (22.3%) – the major component of C. flexuosus - and β-citronellol 
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(18.4%) which equates the major constituent of P. graveolens EO. The antimicrobial 
agency of this mixture used as vapor was evaluated in different tests using a special 
vapor machine. Therefore the number of air-borne bacteria was reduced to 11% in an 
office room within 15 hours. This EO blend could be applied as air disinfectant. 
Moreover, it demonstrated inhibitory activity against A. baumanii, C. difficile, MRSA 
and VRE strains in in-vitro tests.
[163]
 
 
S. officinalis contained an EO whose lead molecules were -thujone (17.8%), 1,8-
cineole (16.3%) and camphor (14.2%). By microdilution tests a high antimicrobial 
activity was determined represented by MIC results between 0.015 and 0.125 l/ml. 
The lowest MIC results were reached in tests involving Bacillus strains (B. cereus, B. 
liqueniformis, B. subtilus) and E. hirae. S. aureus showed a MIC value of 0.031 
l/ml. E. coli, P. aeruginosa, Pseudomonas cepacia, Pseudomonas fluorescens, S. 
enterica and S. typhimurium were also susceptible to the EO referring to MICs of 
0.062 l/ml. The yeasts C. albicans, Pichia subpeliucolosa and Trichosporum 
fermentans exhibited the strongest resistance with MICs of 0.125 l/ml. Due to the 
observed high vapor agency of the volatile oil, it might find application as 
disinfectant against airborne microorganisms.
[164]
 
 
 
Anti-biofilm activity of EOs 
 
Certain bacteria and yeasts can develop biofilms on medicinal devices, such as 
catheters or dialysis access. Since these biofilms are often drug-resistant it is 
important to develop active agents against them.
[165]
 
 
That is why the ability of Boswellia rivae Engl. (Burseraceae) and Boswellia 
papyrifera (Delile ex Caill.) Hochst. (Burseraceae) EO to prevent the development of 
S. aureus, S. epidermidis and Candida-biofilms was evaluated. GC/MS analysis 
revealed limonene (28.0%), α-pinene (13.3%) and 3-carene (15.7%) as the major 
constituents in B. rivae EO. B. papyrifera comprised n-octyl acetate (63.5%) and n-
octanol (17.8%). On the one hand the EOs turned out to be very effective against 
already existing biofilms, on the other hand the development of biofilms was 
inhibited. The generation of C. albicans biofilms was prevented at sub-MIC 
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concentrations of 0.88 g/ml by application of B. rivae EO, whereas the formation of 
S. epidermidis biofilms was inhibited at 0.27 μg/ml by B. papyrifera EO.[165] 
 
Nostro et al. investigated the activity of carvacrol on S. aureus and S. epidermidis 
biofilms. The direct application of carvacrol in liquid form revealed to be more 
efficient than the use of vapor. Therefore, the number of colony forming units 
significantly decreased after exposure to the carvacrol liquid. It can be assumed that 
carvacrol is capable of destroying biofilms formed by Staphylococcus strains.
[166]
 
 
M. alternifolia EO exerted remarkable activity against S. aureus biofilms used in 
concentrations lower than 1% (v/v). These concentrations were twice as high as the 
measured MBC values. The EO diminished the number of biofilm-forming cells 
especially during the first 15 minutes after application. The grade of extinction did 
not change when concentrations higher than 1% (v/v) were applied.
[167]
 
 
 
EOs in combination with synthetic active agents 
 
Combinations of EOs with well-established antibiotics can lead on the one hand to 
additive and synergistic but on the other hand also to antagonistic effects. Synergy 
was observed when R. officinalis EO was combined with ciprofloxacin to inhibit the 
growth of K. pneumoniae. Apart from that, antagonistic interactions were noticed 
using combinations of ciprofloxacin with the EOs of M. alternifolia, M. piperita, R. 
officinalis and T. vulgaris against S. aureus.
[168]
 Otherwise, the combined use of M. 
alternifolia EO with tobramycin exerted synergistic interactions against E. coli and S. 
aureus.
[169]
 
 
The EO of Foeniculum vulgare Mill. (Apiaceae) showed its strongest inhibitory 
effect against S. aureus, E. coli and C. albicans. Synergy was observed in 
combinations with tetracycline and amoxicillin concerning a number of pathogens 
such as E. coli. Also bactericidal activity was noticed starting at concentrations twice 
as high as the MIC results. The EO comprised trans-anethole, fenchone, estragole, 
but also -pinene, -terpinene and limonene.[170] 
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O. vulgare EO exhibited significant antimicrobial activity against multi-drug 
resistant E. coli strains demonstrated by a MIC value of 0.5 l/ml. Synergistic and 
additive activities were noticed against extended-spectrum -lactamase-producing E. 
coli when the EO was combined with various antibiotics. That is why the 
combination of O. vulgare EO with synthetic drugs such as doxycycline, 
fluoroquinolones and lincomycin was recommended allowing a reduction of the drug 
dosage and therefore reducing the risk of side effects.
[171]
 
 
 
EOs against phytopathogenic bacteria 
 
Kotan et al. studied the inhibitory effect of Thymus fallax Fisch. & CA Mey 
(Lamiaceae) and S. spicigera on several phytopathogenic bacteria, including some 
Erwinia, Pseudomonas and Xanthomonas strains. The composition of the EOs was 
examined by GC/MS presenting a high content of thymol, carvacrol, p-cymene and 
-terpinene in T. fallax and S. spicigera. These two plants exhibited a strong 
antibacterial effect against a wide range of agricultural pathogens leading to the idea 
of using their EOs for plant and seed disinfection.
[172]
 
 
Eugenol is capable of reducing the cell number of Xanthomonas campestris pv. 
phaseoli var. fuscans as an experiment with bean seeds revealed. Eugenol was 
applied at concentrations of 2, 4 and 8 mg/ml on infected seeds. Within 72 hours the 
growth significantly decreased about 3, 7 and 16%. Therefore, eugenol could be used 
as seed disinfectant for the prevention of infections caused by this pathogen.
[173]
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YEASTS 
 
Yeasts are unicellular, eukaryotic organisms that belong to the kingdom of fungi. 
They are divided into basidiomycetes and ascomycetes. By developing true hyphae 
or pseudohyphae multicellular cell structures can originate. In order to proliferate 
they are forming buds. The two most well-known yeasts are Saccharomyces 
cerevisiae and Candida albicans which have been studied frequently in order to gain 
knowledge about the eukaryotic cell.
[174]
 
 
In the following chapter recently published studies are summarized which 
exclusively deal with the effect of EOs on yeasts. In most cases C. albicans was 
utilized. 
 
Candida 
Candida species are a natural part of the human flora in the gastrointestinal tract, 
genitor-urinary system and on the skin. Nevertheless, they can cause infections in 
these body regions, since they are opportunistic pathogens. In worse cases even 
systematic infections can emerge. The most common pathogen of Candidiasis is C. 
albicans, followed by Candida glabrata and Candida tropicalis. In newborns also 
Candida parapsilosis is a prevalent pathogen that can lead to candidiasis, including 
candiduria.
[175]
 
Nowadays the majority of nosocomial blood stream infections are linked to Candida 
all over the world. Severe infections usually occur in immunosuppressed patients or 
in persons who are likely to develop infections due to an already existing serious 
disease.
[176]
 
 
Mahboubi et al. investigated the possible synergistic effect of Amphotericin B 
combined with Myrtus communis L. (Myrtaceae) EO whose most abundant substance 
was 1,8-cineole (36.1%), followed by -pinene (22.5%). The MICs of C. albicans, 
Aspergillus niger, A. parasiticus and A. flavus were evaluated. Candida and 
Aspergillus achieved similar MICs - and minimum fungicidal concentrations (MFCs) 
- results with 8-16 l/ml and 16-32 μl/ml, respectively. M. communis EO in 
combination with Amphotericin B showed a remarkable synergistic effect. In this 
case the MIC was significantly lower with 0.06 g/ml against C. albicans compared 
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to the MIC when Amphotericin was used alone (2.00 g/ml). This study 
recommends the combination therapy of Amphotericin B with EOs of M. communis 
against Aspergillus and Candida infections.
[177]
  
 
The main part of Zataria multiflora Boiss (Lamiaceae) EO consisted of thymol with 
27.1% to 64.9% depending on the collection area. Further components were p-
cymene and carvacrol. Whereas the MIC values of the observed bacteria (B. subtilis, 
S. epidermidis, P. aeruginosa, E. coli) were quite high, C. albicans and C. tropicalis 
showed significant susceptibility to the EO with MIC values of 0.25 mg/ml and 
0.062 mg/ml.
[9]
 
 
The use of Ocimum sanctum L. (Lamiaceae) is common practise in ayurvedic 
medicine for its antimicrobial potency. In a recently published study the anticandidal 
activity of this plant was investigated. The main component of the EO which 
comprises 53 compounds was methyl chavicol (44.6%), followed by linalool (21.8%). 
These two constituents turned out to be the most effective ones. The antimicrobial 
study was performed with different C. albicans, C. tropicalis, C. glabrata, C. 
parapsilosis and C. krusei strains of which some were fluconazole/ketoconazole-
resistant and others fluconazole/ketoconazole-sensitive. All of these strains were 
found to be susceptible to O. sanctum EO with MIC results between 0.1 μl/ml and 
0.5 μl/ml. Since fluconazole is very often used to prevent or cure Candida infections, 
drug resistant strains have emerged. The result of this study confirms the idea of 
using O. sanctum EO in combination with established synthetic antifungal agents to 
obtain synergistic effects.
[178]
 In another study about O. sanctum eugenol, linalool 
(which is the most effective constituent), methyl eugenol and 1,8-cineole were 
identified as the main components of the EO. The oil showed higher anticandidal 
activity against C. albicans and C. tropicalis compared to peppermint EO. Moreover 
the mode of action was investigated: The main components of O. sanctum EO exert a 
synergistic effect in inhibiting essential proton pumps. That is why the release of 
hydrogen protons was blocked by the EO.
[179]
 
 
The EO of Origanum vulgare L. (Lamiaceae) whose main components were o-
cymene, thyme and γ-terpinene showed antimicrobial activity against C. albicans 
and C. dubliniensis with MIC values in the range of 200 to 800 g/ml.[180] C. 
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dubliniensis strains can lead to oral candidiasis in HIV patients just as C. albicans 
can. Moreover, this Candida species is capable of getting adjusted to fluconazole 
administration. The germ’s susceptibility to volatile oils could be utilized for the 
treatment of C. dubliniensis infections.
[181]
 
 
The most prevalent substance in S. aromaticum EO was detected to be eugenol 
(85.3%). The antimicrobial effect against several Candida strains and fungi was 
evaluated revealing high agency against all tested microorganisms. Therefore C. 
parapsiliosis was inhibited at a concentration of 0.32 l/ml and the other Candida 
strains including C. albicans, C. glabrata, C. tropicalis and C. krusei at 0.64 l/ml. 
On the one hand the EO impaired ergosterol synthesis and induced cell membrane 
rupture and on the other hand germ tube development was impaired. Eugenol was 
supposed to be responsible for the antimicrobial agency since equal MIC results were 
achieved when this constituent was applied singularly.
[182]
 
 
Nystatin is an effective agent in the cure of fungal diseases. Nevertheless, its use can 
lead to several side effects including for example kidney damage. Minimizing the 
Nystatin dose through combination with EOs might be a solution to reduce adverse 
reactions. The EO of O. vulgare showed synergistic effect when combined with 
Nystatin against C. albicans, C. crusei and C. tropicalis. The Fractional Inhibitory 
Concentration (FIC) levels ranged from 0.11 to 0.17 mg/ml. The GC-MS analysis 
revealed the presence of cymenol (58.6%) and cymene (25.0%). Nystatin associated 
with the EO of Pelargonium graveolens L'Hérit. (Geraniaceae) exhibited lower 
synergistic effect against fewer Candida strains. The main components of P. 
graveolens EO were found to be citronellol (47.3%), geraniol (9.1%) and linalool 
(8.8%). Although no synergistic effect was detected in combination with Melaleuca 
alternifolia Cheel. (Myrtaceae) EO, an additive effect was noticed. The EO of M. 
alternifolia mainly consisted of terpinen–4-ol (30.3%) and γ-terpinene (16.3%).[183]A 
similar study was carried out based on the same EOs. Aim of this study was to 
investigate the potential synergistic effect of these oils in combination with 
Amphotericin B. The antimicrobial potency of the EOs against Candida was tested 
revealing that Pelargonium EO had the highest activity. The synergistic effect of P. 
graveolens EO in combination with Amphotericin B was confirmed in further 
tests.
[184]
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Nevertheless, EOs must be used carefully combined with antibiotics since their 
combination might also imply antagonistic effects. Thus, Mentha piperita L. 
(Lamiaceae), M. alternifolia, Thymus vulgaris L. (Lamiaceae) and R. officinalis EOs 
showed antagonistic effects in combination with Amphotericin B against C. albicans. 
The additive, synergistic and antagonistic effect was often linked to the percentage in 
which the EO and the antibiotic were applied.
[168]
 
 
The volatile oil of Piper ovatum Vahl (Piperaceae) was isolated and examined by 
GC/MS analysis. The detected lead molecules were -amorphene (16.5%), -
muurolene (13.3%) and cis-muurola-4(14),5-diene (14.3%). Antifungal tests proved 
the inhibition of C. tropicalis.
[185]
 
 
The efficiency of geraniol against C. albicans was investigated in an in-vivo 
experiment with mice. Mice were infected with vaginal candidiasis and afterwards 
treated with geraniol. As a consequence, the development of mycelia was inhibited 
but not candidal cell proliferation. When vaginal washing was additionally 
performed to the geraniol administration, also the cell growth was impaired.
[186]
 
 
Dalleau et al. compared the anti-biofilm activity of molecules which are often 
prevalent in EOs. The effect of thymol, carvacrol, α-terpinene, 1,8-cineole, menthol, 
citral, linalool, eugenol, farnesol and geraniol was measured by 24-hour treatment of 
Candida-biofilms which had been developed for 1 to 5 days. Thymol, carvacrol and 
geraniol exhibited the most significant antibiofilm activity against all three tested 
strains, including C. albicans, C. parapsilosis and C. glabrata. Above all, carvacrol 
was capable of reducing Candida-biofilm development regardless of the maturation 
state and attained more than 75% inhibition used in concentrations of 0.03% against 
C. albicans and 0.125% against the other two Candida species. Thymol and geraniol 
showed similar potency against C. parapsilosis biofilms used at 0.125% independent 
on their age.
[187]
 
 
Giordani et al. compared the anticandidal effect of several Thymus types, Origanum 
majorana L. (Lamiaceae) and R. officinalis L. collected in Algeria. It is the first 
study including Thymus numidicus Poiret. (Lamiaceae) which presented the highest 
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activity against Candida reaching a MIC of 0.000479 µg/ml. This equates 1357 fold 
higher potency compared to Amphotericin B whose measured MIC was found to be 
0.65 µg/ml. The main component in the EO of T. numidicus was identified as thymol. 
O. majorana volatile oil presented a MIC of 1.564 µg/ml. The O. majorana EO 
comprised 25.4% of thymol, 21.4% of carvacrol and 20.8% of γ-terpinene as main 
constituents. The EO of T. vulgaris L. (Lamiaceae) whose main constituents were p-
cymene (26.4%) and thymol (25.6%) showed likewise a low MIC value of 3.71 
µg/ml. R. officinalis EO whose MIC was determined to be 2.208 g/ml consisted 
mainly of α-pinene (19.7%), camphor (12.6%) and borneol (11.2%). Thymus 
algeriensis Boiss. et Reut (Lamiaceae) showed the highest MIC value of 11.38 
µg/ml. This EO was characterized to contain 25.5% α-pinene, 7.7% 1,8-cineole and  
8.5% camphor. The constituents of the singular EOs were almost the same but their 
ratio differed significantly. The dimension of the antifungal activity was assumed to 
be dependent on the quantity of carvacrol, thymol, γ-terpinene and p-cymene found 
in the EO.
[188]
 
 
Cymbopogon citratus (DC.) Stapf (Poaceae) EO exhibited antifungal potency against 
various Candida species, including C. albicans, C. parapsilosis, C. glabrata, C. 
tropicalis and C. krusei of which C. albicans appeared to be the most susceptible one. 
The GC analysis identified citral as major component with a percentage of 76%. 
Since equal anticandidal results were obtained when citral was singularly used, it is 
obviously the most powerful constituent.
[189]
 
 
The essential volatiles of Pinus koraiensis Siebold et Zucc (Pinaceae) cones was 
investigated by GC-MS analysis revealing the presence of limonene (27.9%), -
pinene (23.9%) and -pinene (12.0%). The antimicrobial effect was examined by 
both broth microdilution and agar disk diffusion tests. In contrast to the relatively 
weak antibacterial activity with MICs equally or higher than 21.8 mg/ml much better 
efficacy was noticed against the involved yeast strains, such as C. neoformans (MIC 
of 0.136 mg/ml) or C. glabrata (MIC >0.545 mg/ml).
[190]
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Cryptococcus 
Cryptococcus neoformans enters the human body through inhalation. Whereas it is 
not threatening for healthy persons, it can lead to critical infections in immuno-
compromised patients, cancer or HIV-patients. The germs are able to disseminate to 
the brain causing meningoencephalitis.
[191]
 
 
The EO of Thymus x viciosoi (Pau) R. Morales (Lamiaceae) whose main components 
were thymol, carvacrol and p-cymene proved antifungal activity using broth 
microdilution assays. The quite low MIC values ranged from 0.08 to 0.32 l/ml 
against all utilized yeasts and fungis. The lowest MIC of 0.08 emerged at tests 
against C. neoformans and Trichophyton mentagrophytes. Since similar low MIC 
values were measured during tests using the isolated components carvacrol and 
thymol instead of the whole EO, they are assumed to be responsible for the 
impressive antifungal efficiency. The effect of the EO on the plasma membrane was 
observed by flow cytometry showing damage of the cell membrane, inhibition of the 
cell metabolism and as a result cell death.
[192]
  
 
The EO of Pinus densiflora Siebold et Zucc. (Pinaceae) exhibited antifungal activity. 
The evaluated MIC results for C. neoformans were determined to be 0.545 mg/ml 
whereas the activity against C. glabrata was not that high demonstrated by a MIC 
value of 2.18 mg/ml. By means of GC/MS the main components of the EO were 
found to be -phellandrene (16.7%) and -pinene (14.9%).[193] 
 
 
 
 
 
 
 
 
 
 
 
 
 55 
ANTIFUNGALS 
 
This chapter deals with new findings concerning the antifungal activity of EOs. 
Various molds, dermatophytes and phytopathogenic fungi were included in these 
studies. 
 
 
EOs against dermatophytes 
 
The designation ‘dermatophytic fungi’ comprises different kinds of Epidermophyton, 
Microsporum and Trichophyton species. These pathogens are responsible for the 
generation of fungal infections concerning the human skin, nails and hair.
[194]
 
 
effective against EO main constituents test 
method 
Ref. 
Microsporum 
canis, 
Microsporum 
gypseum, 
Trichophyton 
rubrum, 
Fonsecaea 
pedrosoi 
Artemisia 
absinthium L. 
(Asteraceae) 
trans-sabinyl 
acetate (26.4%) 
agar 
diffusion 
test 
[84]
 
M. canis, M. 
gypseum, T. 
rubrum, F. 
pedrosoi 
Artemisia biennis 
Willd. (Asteraceae) 
(E)--farnesene 
(40.0%), (Z)--
ocimene (34.7%) 
agar 
diffusion 
test 
[84]
 
M. canis, M. 
gypseum, T. 
rubrum, F. 
pedrosoi 
Artemisia 
ludoviciana Nutt. 
(Asteraceae) 
1,8-cineole 
(22.0%), camphor 
(15.9%) 
agar 
diffusion 
test 
[84]
 
Trichophyton 
mentagrophytes 
var. interdigitale 
Citrus macroptera 
Lour. (Rutaceae) 
-pinene (33.3%), 
-pinene (25.3%), 
p-cymene (17.6%) 
MIC = 
12.5 
g/ml 
[195]
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M. canis Croton 
argyrophylloides 
Muell. Arg. 
(Euphorbiaceae) 
spathulenol 
(20.3%), 
bicyclogermacrene 
(11.7%) 
MIC = 9 
to 19 
g/ml 
[196]
 
M. canis Croton zenhtneri 
Pax & Hoffman 
(Euphorbiaceae) 
estragole (72.9%) MIC = 
620 to 
1250 
g/ml 
[196]
 
M. canis, T. 
mentagrophytes, 
T. rubrum 
Magnolia liliflora 
Desr. 
(Magnoliaceae) 
 disk 
diffusion 
test, MIC 
= 62.5 to 
500 g/ml 
[197]
 
M. canis, T. 
rubrum, T. 
mentagrophytes  
Nandina domestica 
Thunb. 
(Berberidaceae) 
 MIC = 
62.5 to 
500 g/ml 
[198]
 
M. gypseum, M. 
canis, T. 
mentagrophytes, 
T. rubrum 
Ocimum forskolei 
Benth (Lamiaceae) 
estragole diffusion 
test 
[109]
 
T. 
mentagrophytes; 
T. rubrum; M. 
gypseum 
Plinia 
cerrocampanensis 
Barrie (Myrtaceae) 
-bisabolol 
(42.8%) 
MIC = 32 
μg/ml; 
MIC = 
62.5 
μg/ml; 
MIC = 
125 μg/ml 
[36]
 
Epidermophyton 
floccosum, T. 
rubrum, T. 
mentagrophytes, 
M. canis, M. 
gypseum 
Syzygium 
aromaticum (L.) 
Merr. Et Perry 
(Myrtaceae) 
eugenol (85.3%) MIC = 
0.08 to 
0.16 l/ml 
[182]
 
T. Zanthoxylum -bisabolol, disk 
[21]
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mentagrophyes, 
E. floccosum, M. 
gypseum 
tingoassuiba St.-
Hil. (Rutaceae) EO 
methyl-N-
methylanthranilate 
diffusion 
test 
 
Table 8: EOs against dermatophytes 
 
The impact of the cultivation place on the chemical composition and therefore on the 
antimicrobial activity is revealed in the below-mentioned study. 
The chemical composition of the EO obtained from D. carota subsp. carota differed 
depending on the growing location. That is why the plants from Portugal mainly 
comprised geranyl acetate and -pinene whereas -bisabolene and 11--(H)-
himachal-4-en-1--ol were the primary constituents in the Sardinian plants. Both 
EOs exhibited antifungal effects especially against the yeast C. neoformans and 
dermatophytic fungi, such as E. floccosum, M. canis, M. gypseum, T. mentagrophytes 
and T. rubrum. The plants from Sardinia showed the strongest activity with MICs 
ranging from 0.16 to 0.64 l/ml.[199] Of all tested fungi the dermatophytic strains 
showed the most distinctive vulnerability to the EO of Daucus carota subsp. 
halophilus (Brot.) A. Pujadas (Apiaceae) which mainly comprised sabinene, -
pinene, limonene and elemicin. Therefore, the MIC values ranged from to 0.16 to 
0.64 l/ml in tests including Epidermophyton floccosum, M. canis, M. gypseum, T. 
mentagrophytes and T. rubrum. Moreover, increased elemicin levels correlated with 
stronger fungistatic effects.
[200]
 
 
Lavandula pedunculata (Miller) Cav. (Lamiaceae) EO was divided into different 
chemotypes depending on the major constituent which was either 1,8-cineole or 
fenchone. Dermatophytes such as M. canis, M. gypseum, T. mentagrophytes and T. 
rubrum showed higher susceptibility to the EOs in comparison to Aspergillus species 
and yeasts. Especially strong activity was assessed in tests with sub-chemotypes 
which additionally comprised high camphor levels achieving MIC results between 
0.32 and 0.64 l/ml.[201] 
 
Besides of inhibiting the growth of dermatophytic fungi some EOs, such as M. 
liliflora EO, additionally succeeded in impairing the development of spores.
[197]
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In an in-vivo experiment involving horses which suffered from a Trichophyton 
equinum infection the antifungal potential of Melaleuca alternifolia Cheel. 
(Myrtaceae) EO against these pathogens was proved. The application of the volatile 
oil revealed to be as successful as the treatment with enilconazole. As a result, the 
horses recovered from the fungal infections within one month.
[202]
 
 
The prevalent substances in the EOs which were investigated for their activity 
against dermatophytic fungi cannot be assigned to one particular chemical group, but 
it seems that especially sesquiterpenes, phenylpropanoids and bicyclic non-phenolic 
monoterpenes are connected with strong antifungal effects against skin-infection 
causing fungi. 
 
 
EOs against molds 
 
Molds – in most cases Aspergillus species - can lead to invasive infections especially 
in patients with weakened immune system. Not all species are susceptible to the 
established active agents. Moreover, the emergence of resistance to applied drugs 
was observed.
[203]
 In addition, the exposure to molds and their spores is assumed to 
be connected to asthmatic and allergic reactions.
[204]
 Many molds are able to produce 
toxic molecules, so-called mycotoxins, which represent a health-damaging threat to 
human beings since some of them (e.g. aflatoxins) act as carcinogens. These harmful 
substances are taken up by the ingestion of contaminated food. Especially cereals and 
nuts are susceptible to fungal infestation.
[205]
 
 
effective against EO main constituents test 
method 
Ref. 
Aspergillus flavus Aegle marmelos L. 
Correa (Rutaceae) 
dl-limonene 
(39.2%) 
MIC = 
750 l/l 
[206]
 
Aspergillus 
parasiticus, A. 
flavus 
Ageratum 
conyzoides L. 
(Asteraceae) 
precocene I, 
precocene II  
disk 
diffusion 
test 
[82]
 
[207]
 
Geotrichum 
candidum; 
Artemisia incana 
(L.) Druce 
camphor (19.0%), 
borneol (18.9%), 
MIC = 
31.3 
[41]
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Aspergillus and 
Penicillium species, 
Cladosporium 
herbarum, Absidia 
repens, 
Trichothecium 
roseum 
(Asteraceae) 1,8-cineole (14.5%) g/ml; 
MIC = 
125 to 
500 
g/ml 
A. flavus, 
Aspergillus niger, 
Aspergillus 
glaucus, 
Aspergillus 
ochraceus, 
Fusarium and 
Colletotrichum 
species  
Chenopodium 
ambrosioides L. 
(Chenopodiaceae) 
(Z)-ascaridole 
(61.4%) 
 
[208]
 
Alternaria 
alternata, A. niger, 
Penicillium 
roquefortii, 
Fusarium 
oxysporum 
Cymbopogon 
citratus (DC.) Stapf 
(Poaceae) 
 MIC = 
0.062 to 
0.31 
l/ml 
[209]
 
Mucor 
ramamnianus, 
Aspergillus 
westerdijkiae 
Juniperus 
phoenicea L. 
(Cupressaceae) 
-pinene agar 
diffusion 
test 
[100]
 
A. niger, Rhizopus 
oryzae 
Laurus nobilis L. 
(Lauraceae) 
1,8-cineole (60%) MIC = 
0.02% 
(v/v) 
[46]
 
A. niger Matricaria 
chamomilla 
L.(Asteraceae) 
-bisabolol (56.9%)  
[210]
 
A. ochraceus, M. 
ramamnianus 
Mentha longifolia 
L. (Lamiaceae) 
pulegone (54.4%) diffusion 
test 
[104]
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A. ochraceus, M. 
ramamnianus 
Mentha viridis L. 
(Lamiaceae) 
carvone (50.5%) diffusion 
test 
[104]
 
Cladosporium 
cladosporioides 
Myrica gale L. 
(Myricaceae) 
-pinene, 
germacrone 
dilution 
test 
[211]
 
A. flavus, Fusarium 
tabacinum, 
Fusarium solani 
Nepeta cataria L. 
(Lamiaceae) 
4a,7,7a-
nepetalactone 
(70.4%) 
disk 
diffusion 
test, MIC 
= 15.62 
g/ml 
[108]
 
Aspergillus species, 
A. alternata, 
Penicillium species, 
Fusarium nivale  
Ocimum sanctum L. 
(Lamiaceae) 
eugenol (61.3%) MIC = 
0.3 l/ml 
[212]
 
C. cladosporioides, 
Cladosporium 
sphareospermum 
Piper divaricatum 
G.F.W.Meyer. 
(Piperaceae) 
methyleugenol  
(63.8%), eugenol 
(23.6%) 
dilution 
test 
[213]
 
A. niger Pituranthos 
chloranthus Benth. 
and Hook. 
(Apiaceae) 
terpinen-4-ol 
(30.3%) 
MIC = 
7.5 mg/l 
[117]
 
A. parasiticus Rosmarinus 
officinalis L. 
(Lamiaceae) 
piperitone (23.7%), 
-pinene (14.9%), 
limonene (14.9%) 
MIC = 
1750 
ppm 
[214]
 
Ashbiya gossypii, 
A. niger, R. oryzae, 
Trichoderma reesei 
Salvia officinalis L. 
(Lamiaceae) 
-thujone (17.8%), 
1,8-cineole (16.3%), 
camphor (14.2%) 
MIC = 
0.031 to 
0.250 
l/ml 
[164]
 
A. flavus, A. 
parasiticus 
Satureja hortensis 
L. (Lamiaceae) 
thymol, carvacrol diffusion 
test, MIC 
= 6.25 
µl/ml 
[215]
 
 
[216]
 
A. flavus, A. niger, 
Aspergillus 
S. aromaticum eugenol (85.3%) MIC = 
0.32 to 
[182]
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fumigatus 0.64 
l/ml 
A. alternata Thuja orientalis L. 
(Cupressaceae) 
-pinene (29.2%), 
-3-carene (20.1%) 
diffusion 
test 
[217]
 
A. parasiticus Trachyspermum 
copticum (L.) Link 
(Apiaceae) 
thymol (37.2%), p-
cymene (32.3%) 
MIC = 
600 ppm 
[214]
 
A. flavus Zataria multiflora 
Boiss (Lamiaceae) 
carvacrol (71.12%) MIC = 
400 ppm 
[218]
 
A. flavus, A. niger, 
Fusarium 
moniliforme 
Zingiber officinale 
Rosc. 
(Zingiberaceae) 
geranial (25.9%) disk 
diffusion 
test 
[143]
 
A. niger  camphor MIC = 2 
l/ml 
[142]
 
A. niger  -pinene MIC = 4 
l/ml 
[142]
 
 
Table 9: EOs against molds 
 
The prevalent substances of Lippia alba (Mill.) N.E. Brown (Verbenaceae) EO neral 
(14.2%) and geranial (22.2%) as well as the entire EO inhibited on the one hand the 
aflatoxin B1 production and on the other hand the growth of A. flavus. Moreover, the 
growth of other Aspergillus species and Fusarium strains was significantly impaired. 
That is why this EO seemed to be suitable for the preservation of food.
[219]
A further 
study involving two different chemotypes of L. alba was published emphasizing the 
different antimicrobial activity of each chemotyp. The citral chemotype of L. alba 
EO which consisted to 30.5% of geranial and to 23.6% of neral inhibited the growth 
of A. fumigatus at a concentration of 78.7 g/ml. The carvone chemotype which 
comprised carvone (25.3%), limonene (22.4%), geranial and neral (10.4% each) was 
found to be not as successful since the measured MIC values revealed to be always 
higher than 500 g/ml against all microorganisms. This circumstance is probably 
linked to the particular citral content since citral exhibited high efficiency in 
inhibiting A. fumigatus (MIC of 62.5 g/ml) and C. krusei (39.7 g/ml). Also 
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geraniol (6.3% of the citral chemotype) and citronellal were tested singularly 
revealing strong antifungal potency.
[220]
 
 
The growth as well as the mycotoxin production of molds was significantly inhibited 
by the use of EOs. As a consequence, their application as bio-preservatives seems to 
be possible. The EOs of the following plants led to a noteworthy reduction or to an 
entire inhibition of the aflatoxin production: A. conyzoides
[207]
, A. marmelos
[206]
, L. 
alba
[219]
, O. sanctum
[212]
, R. officinalis
[214]
, S. hortensis
[216]
, T. copticum
[214]
 and Z. 
multiflora
[218]
. 
 
The growth of A. flavus was entirely impeded by applying the EO of S. hortensis EO 
at the MIC on lemons one week before they were exposed to the pathogens.
[215]
 In 
addition, this EO and its individual components thymol and carvacrol effectively 
suppressed the growth as well as the aflatoxin B1 and G1 synthesis of A. 
parasiticus.
[216]
 
 
Besides of inhibiting the production of aflatoxines also other mycotoxins - such as 
deoxynivalenol and its derivates - were impaired by the use of EOs. 
Piperitone were separated from the EO of Eucalyptus dives Schauer (Myrtaceae). 
Precocenes I and II were likewise purified from the other constituents of Matricaria 
recutita L. (Asteraceae) EO. All these substances were found to be capable of 
suppressing the synthesis of deoxynivalenol – a mycotoxin of Fusarium strains. In 
the present study the isolated substances effectively inhibited the biosynthesis of 
these harmful molecules in Fusarium graminearum.
[221]
 Also the aflatoxin G1 
synthesis of A. parasiticus was effectively suppressed by the application of M. 
recutica EO whereas the aflatoxin B1 levels were not reduced. Moreover the 
synthesis of the mycotoxin 3-acetyldeoxynivalenol was diminished in F. 
graminearum. The active agents were identified as (Z)- and (E)-spiroethers of which 
the latter ones displayed higher efficacy.
[222]
 
 
One of the modes of action seems to be the destruction of existing mycelia as well as 
the inhibition of the development of new mycelia as some studies proved. 
Therefore, the volatile oil of Citrus sinensis (L.) Osbeck (Rutaceae) which was 
noticed to be rich in limonene (84.2%) exerted antifungal activity against A. niger by 
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destroying its mycelial cell walls as microscopy techniques revealed. The fungal 
growth completely stopped by using a concentration of 3.0 μg/ml which was at the 
same time fungicidal.
[223]
 The same effect was observed against the hyphae of A. 
niger by applying the EO of M. chamomilla.
[210]
 Furthermore, the EO of A. 
conyzoides inhibited the formation of mycelia
[82]
, just as Z. multiflora EO did.
[218]
 
 
Moreover, EOs were found to be capable of inhibiting the formation of spores. 
Chamazulene was the lead molecule in Achillea millefolium L. (Asteraceae) EO 
constituting 42.2% of the whole oil. At the investigated concentration of 0.25 l/ml 
the growth of Aspergillus nidulans was significantly reduced. This EO exerted 
genotoxic effects against the fungal cells and suppressed the development of 
spores.
[224]
 
 
As the below-mentioned study shows the fungistatic activity of EOs can be 
influenced by the present pH-level. Penicillium verrucosum, Penicillium expansum 
and A. ochraceus were more sensitive to Ocimum gratissimum L. (Lamiaceae) EO 
compared to the EOs of Thymus vulgaris L. (Lamiaceae) and C. citratus. All EOs 
showed stronger effects against the Penicillium strains at a high pH-value of 9 
whereas A. ochraceus was more vulnerable at a low pH-value of 3.
[225]
 
 
In the present studies EOs effectively inhibited the growth of molds, but also the 
production of mycotoxins, mycelia and spores. Due to these properties they could be 
used among others for the preservation of food, e.g. for active-packaging as a study 
with Cinnamomum zeylanicum Breyne (Lauraceae) EO revealed.  
Hence, C. zeylanicum EO which was predominated by the antimicrobially active 
substance trans-cinnamaldehyde was found to be capable of inhibiting the growth of 
Rhizopus stolonifer in bread when the wrapping included this EO at a percentage of 
6% (w/w).
[226]
 
 
By regarding the chemical composition of EOs which exhibit strong antifungal 
activity against molds no obvious pattern becomes apparent. Therefore, some EOs 
were predominated by non-phenolic terpenes while others exhibited a high 
percentage of sesquiterpenes, phenolic monoterpenes or phenylpropanoids. 
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EOs against phytopathogenic fungi 
 
effective against EO main 
constituents 
test method Ref. 
Botrytis fabae, F. 
oxysporum, Pythium 
debaryanum, 
Rhizocotonia solani 
Artemisia 
judaica L. 
(Asteraceae) 
Trans-ethyl 
cinnamate, 
piperitone 
 
[227]
 
Colletotrichum 
gloeosporioides, F. 
oxysporum, F. solani, 
Ganoderma australe, 
Pestalotiopsis funereal, 
R. solani 
Calocedrus 
macrolepis var. 
formosana 
Florin 
(Cupressaceae) 
-pinene 
(44.2%), 
limonene 
(21.6%) 
 
[228]
 
Botrytis cinerea Foeniculum 
vulgare (L.) 
Mill. 
(Apiaceae) 
  
[229]
 
Botrytis, Fusarium and 
Alternaria species 
Origanum 
acutidens 
(Hand.-Mazz.) 
Ietswaart 
(Lamiaceae) 
carvacrol 
(87.0%) 
 
[230]
 
A. alternata, B. 
cinerea, F. oxysporum 
R. officinalis p-cymene 
(44.0%), linalool 
(20.5%) 
disk-
diffusion test 
[231]
 
Colletotrichum 
acutatum, 
Colletotrichum 
fragariae, C. 
gloeosporioides  
Salvia rosifolia 
Sm. 
(Lamiaceae) 
-pinene, 
1,8-cineole 
dilution test 
[18]
 
 
Table 10: EOs against phytopathogenic fungi  
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Eugenol was isolated from Syzygium aromaticum (L.) Merr. Et Perry (Myrtaceae) 
EO and subsequently used for the inhibition of phytopathogens. At a concentration of 
150 l/l the production of mycelia was totally suppressed in B. cinerea, Monilinia 
fructigena, P. expansum and Phlyctema vagabunda. Using a combination of eugenol 
and lecithin which protected the fruits from the phytotoxic effects of eugenol the 
occurrence of these fungal infections in stored apples was effectively diminished 
indicating its potential use as bio-fungicide.
[232]
 
In addition, eugenol was detected to obtain fungistatic effects against fungi which 
infect plant seeds such as Fusarium moniliforme, Alternaria solani, R. solani and 
Colletotrichum species. Therefore, this substance inhibited the growth of the 
pathogens, but also led to the inhibition of mycelia formation and to the destruction 
of spores.
[233]
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